<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Endocrinol (Lausanne)</journal-id><journal-id journal-id-type="iso-abbrev">Front Endocrinol (Lausanne)</journal-id><journal-id journal-id-type="pmc-domain-id">1753</journal-id><journal-id journal-id-type="pmc-domain">frontendo</journal-id><journal-id journal-id-type="publisher-id">Front. Endocrinol.</journal-id><journal-title-group><journal-title>Frontiers in Endocrinology</journal-title></journal-title-group><issn pub-type="epub">1664-2392</issn><publisher><publisher-name>Frontiers Media SA</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10040837</article-id><article-id pub-id-type="pmcid-ver">PMC10040837.1</article-id><article-id pub-id-type="pmcaid">10040837</article-id><article-id pub-id-type="pmcaiid">10040837</article-id><article-id pub-id-type="pmid">36992801</article-id><article-id pub-id-type="doi">10.3389/fendo.2023.1102348</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Endocrinology</subject><subj-group><subject>Original Research</subject></subj-group></subj-group></article-categories><title-group><article-title>Disparities in health condition diagnoses among aging transgender and cisgender medicare beneficiaries, 2008-2017</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Hughto</surname><given-names initials="JMW">Jaclyn M. W.</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref><xref rid="fn001" ref-type="author-notes">
<sup>*</sup>
</xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://loop.frontiersin.org/people/2103786"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Varma</surname><given-names initials="H">Hiren</given-names></name><xref rid="aff4" ref-type="aff">
<sup>4</sup>
</xref><xref rid="aff5" ref-type="aff">
<sup>5</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Babbs</surname><given-names initials="G">Gray</given-names></name><xref rid="aff4" ref-type="aff">
<sup>4</sup>
</xref><xref rid="aff5" ref-type="aff">
<sup>5</sup>
</xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://loop.frontiersin.org/people/2203705"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Yee</surname><given-names initials="K">Kim</given-names></name><xref rid="aff6" ref-type="aff">
<sup>6</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Alpert</surname><given-names initials="A">Ash</given-names></name><xref rid="aff4" ref-type="aff">
<sup>4</sup>
</xref><xref rid="aff5" ref-type="aff">
<sup>5</sup>
</xref><xref rid="aff7" ref-type="aff">
<sup>7</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Hughes</surname><given-names initials="L">Landon</given-names></name><xref rid="aff8" ref-type="aff">
<sup>8</sup>
</xref><xref rid="aff9" ref-type="aff">
<sup>9</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ellison</surname><given-names initials="J">Jacqueline</given-names></name><xref rid="aff10" ref-type="aff">
<sup>10</sup>
</xref><xref rid="aff11" ref-type="aff">
<sup>11</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Downing</surname><given-names initials="J">Jae</given-names></name><xref rid="aff6" ref-type="aff">
<sup>6</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Shireman</surname><given-names initials="TI">Theresa I.</given-names></name><xref rid="aff4" ref-type="aff">
<sup>4</sup>
</xref><xref rid="aff5" ref-type="aff">
<sup>5</sup>
</xref></contrib></contrib-group><aff id="aff1">
<sup>1</sup>
<institution>Center for Health Promotion and Health Equity, Brown University School of Public Health</institution>, <addr-line>Providence, RI</addr-line>, <country>United States</country>
</aff><aff id="aff2">
<sup>2</sup>
<institution>Departments of Behavioral and Social Sciences and Epidemiology, Brown University School of Public Health</institution>, <addr-line>Providence, RI</addr-line>, <country>United States</country>
</aff><aff id="aff3">
<sup>3</sup>
<institution>The Fenway Institute, Fenway Health</institution>, <addr-line>Boston, MA</addr-line>, <country>United States</country>
</aff><aff id="aff4">
<sup>4</sup>
<institution>Center for Gerontology &amp; Healthcare Research, Brown University School of Public Health</institution>, <addr-line>Providence, RI</addr-line>, <country>United States</country>
</aff><aff id="aff5">
<sup>5</sup>
<institution>Department of Health Services Policy &amp; Practice, Brown University School of Public Health</institution>, <addr-line>Providence, RI</addr-line>, <country>United States</country>
</aff><aff id="aff6">
<sup>6</sup>
<institution>Oregon Health &amp; Science University - Portland State University School of Public Health</institution>, <addr-line>Portland, OR</addr-line>, <country>United States</country>
</aff><aff id="aff7">
<sup>7</sup>
<institution>Department of Public Health Sciences, University of Rochester Medical Center</institution>, <addr-line>Rochester, NY</addr-line>, <country>United States</country>
</aff><aff id="aff8">
<sup>8</sup>
<institution>Department of Health Behavior and Health Education, University of Michigan School of Public Health</institution>, <addr-line>Ann Arbor, MI</addr-line>, <country>United States</country>
</aff><aff id="aff9">
<sup>9</sup>
<institution>Institute for Social Research, University of Michigan</institution>, <addr-line>Ann Arbor, MI</addr-line>, <country>United States</country>
</aff><aff id="aff10">
<sup>10</sup>
<institution>Department of Health Policy and Management, University of Pittsburgh School of Public Health</institution>, <addr-line>Pittsburgh, PA</addr-line>, <country>United States</country>
</aff><aff id="aff11">
<sup>11</sup>
<institution>Center for Innovative Research on Gender Health Equity (CONVERGE), University of Pittsburgh Department of Medicine</institution>, <addr-line>Pittsburgh, PA</addr-line>, <country>United States</country>
</aff><author-notes><fn fn-type="edited-by"><p>Edited by: Arjee Restar, University of Washington, United States</p></fn><fn fn-type="edited-by"><p>Reviewed by: George Brown, East Tennessee State University, United States; Jane Lee, University of Washington, United States</p></fn><corresp id="fn001">*Correspondence: Jaclyn M. W. Hughto, <email xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="mailto:jaclyn_hughto@brown.edu">jaclyn_hughto@brown.edu</email></corresp><fn fn-type="other" id="fn002"><p>This article was submitted to Translational Endocrinology, a section of the journal Frontiers in Endocrinology</p></fn></author-notes><pub-date pub-type="epub"><day>13</day><month>3</month><year>2023</year></pub-date><pub-date pub-type="collection"><year>2023</year></pub-date><volume>14</volume><issue-id pub-id-type="pmc-issue-id">427503</issue-id><elocation-id>1102348</elocation-id><history><date date-type="received"><day>18</day><month>11</month><year>2022</year></date><date date-type="accepted"><day>21</day><month>2</month><year>2023</year></date></history><pub-history><event event-type="pmc-release"><date><day>01</day><month>01</month><year>2023</year></date></event><event event-type="pmc-live"><date><day>28</day><month>03</month><year>2023</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2023-03-30 12:10:12.593"><day>30</day><month>03</month><year>2023</year></date></event></pub-history><permissions><copyright-statement>Copyright &#169; 2023 Hughto, Varma, Babbs, Yee, Alpert, Hughes, Ellison, Downing and Shireman</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Hughto, Varma, Babbs, Yee, Alpert, Hughes, Ellison, Downing and Shireman</copyright-holder><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="fendo-14-1102348.pdf"/><abstract><sec><title>Introduction</title><p>The objective of this research is to provide national estimates of the prevalence of health condition diagnoses among age-entitled transgender and cisgender Medicare beneficiaries. Quantification of the health burden across sex assigned at birth and gender can inform prevention, research, and allocation of funding for modifiable risk factors.</p></sec><sec><title>Methods</title><p>Using 2009&#8211;2017 Medicare fee-for-service data, we implemented an algorithm that leverages diagnosis, procedure, and pharmacy claims to identify age-entitled transgender Medicare beneficiaries and stratify the sample by inferred gender: trans feminine and nonbinary (TFN), trans masculine and nonbinary (TMN), and unclassified. We selected a 5% random sample of cisgender individuals for comparison. We descriptively analyzed (means and frequencies) demographic characteristics (age, race/ethnicity, US census region, months of enrollment) and used chi-square and t-tests to determine between- (transgender vs. cisgender) and within-group gender differences (e.g., TMN, TFN, unclassified) difference in demographics (p&lt;0.05). We then used logistic regression to estimate and examine within- and between-group gender differences in the predicted probability of 25 health conditions, controlling for age, race/ethnicity, enrollment length, and census region.</p></sec><sec><title>Results</title><p>The analytic sample included 9,975 transgender (TFN n=4,198; TMN n=2,762; unclassified n=3,015) and 2,961,636 cisgender (male n=1,294,690, female n=1,666,946) beneficiaries. The majority of the transgender and cisgender samples were between the ages of 65 and 69 and White, non-Hispanic. The largest proportion of transgender and cisgender beneficiaries were from the South. On average, transgender individuals had more months of enrollment than cisgender individuals. In adjusted models, aging TFN or TMN Medicare beneficiaries had the highest probability of each of the 25 health diagnoses studied relative to cisgender males or females. TFN beneficiaries had the highest burden of health diagnoses relative to all other groups.</p></sec><sec><title>Discussion</title><p>These findings document disparities in key health condition diagnoses among transgender Medicare beneficiaries relative to cisgender individuals. Future application of these methods will enable the study of rare and anatomy-specific conditions among hard-to-reach aging transgender populations and inform interventions and policies to address documented disparities.</p></sec></abstract><kwd-group><kwd>transgender</kwd><kwd>Medicare</kwd><kwd>aging</kwd><kwd>older adults</kwd><kwd>insurance claims</kwd><kwd>chronic conditions</kwd><kwd>health disparities</kwd><kwd>diagnoses</kwd></kwd-group><funding-group><award-group><funding-source id="cn001"><institution-wrap><institution>Centers for Medicare and Medicaid Services
</institution><institution-id institution-id-type="doi">10.13039/100005227</institution-id></institution-wrap></funding-source></award-group><award-group><funding-source id="cn002"><institution-wrap><institution>National Institute on Aging
</institution><institution-id institution-id-type="doi">10.13039/100000049</institution-id></institution-wrap></funding-source></award-group><award-group><funding-source id="cn003"><institution-wrap><institution>Eunice Kennedy Shriver National Institute of Child Health and Human Development
</institution><institution-id institution-id-type="doi">10.13039/100009633</institution-id></institution-wrap></funding-source></award-group><award-group><funding-source id="cn004"><institution-wrap><institution>Brown University
</institution><institution-id institution-id-type="doi">10.13039/100006418</institution-id></institution-wrap></funding-source></award-group><award-group><funding-source id="cn005"><institution-wrap><institution>National Institutes of Health
</institution><institution-id institution-id-type="doi">10.13039/100000002</institution-id></institution-wrap></funding-source></award-group><funding-statement>This work was supported by a Brown University Catalyst Award (MPI: JH &amp; TS: GR200019). Data access was provided through a Health Equity Research Award (MPI: JH &amp; TS) provided by the Centers for Medicare &amp; Medicaid Services. LH was supported by the Rackham Merit Fellowship, the National Institute on Aging (T32 AG000221), and the Eunice Kennedy Shriver National Institute of Child Health and Development (T32 HD00733931). The content is solely the responsibility of the authors and does not necessarily represent the official views of funders.</funding-statement></funding-group><counts><fig-count count="1"/><table-count count="2"/><equation-count count="0"/><ref-count count="121"/><page-count count="14"/><word-count count="7893"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="s1"><title>Introduction</title><p>Transgender people in the United States (US) experience significant health disparities throughout their life course relative to cisgender (non-transgender) people (<xref rid="B1" ref-type="bibr">1</xref>&#8211;<xref rid="B6" ref-type="bibr">6</xref>). These disparities stem from multilevel sources of stigma that serve as sources of chronic stress as well as barriers to accessing essential resources such as healthcare, employment, and income (<xref rid="B7" ref-type="bibr">7</xref>&#8211;<xref rid="B9" ref-type="bibr">9</xref>). While extensive community-based research drawn from convenience samples (<xref rid="B10" ref-type="bibr">10</xref>, <xref rid="B11" ref-type="bibr">11</xref>), and research using state or national data has assessed the health of transgender youth and adults overall (<xref rid="B12" ref-type="bibr">12</xref>&#8211;<xref rid="B14" ref-type="bibr">14</xref>) and relative to cisgender people (<xref rid="B15" ref-type="bibr">15</xref>&#8211;<xref rid="B18" ref-type="bibr">18</xref>), a dearth of national studies have compared the health of an exclusively aging (i.e., age 65 or older) sample of transgender and cisgender adults.</p><p>The risk of being diagnosed with a chronic health condition, such as cancer, HIV, depression, osteoporosis, and dementia, increases as one ages (<xref rid="B19" ref-type="bibr">19</xref>, <xref rid="B20" ref-type="bibr">20</xref>). Aging transgender adults are expected to be at an even higher risk of developing physical and mental health conditions than their cisgender peers due to stigma-related stress experienced throughout their lives and barriers to accessing quality healthcare (<xref rid="B9" ref-type="bibr">9</xref>, <xref rid="B21" ref-type="bibr">21</xref>&#8211;<xref rid="B25" ref-type="bibr">25</xref>). Although researchers are increasingly studying the health of aging transgender adults (<xref rid="B26" ref-type="bibr">26</xref>&#8211;<xref rid="B28" ref-type="bibr">28</xref>), and some national studies have explored disparities among predominantly aging populations relative to cisgender groups (<xref rid="B29" ref-type="bibr">29</xref>&#8211;<xref rid="B32" ref-type="bibr">32</xref>), no national research, to our knowledge, has explored within- (e.g., trans feminine people vs. trans masculine people) and between- (e.g., transgender vs. cisgender) group gender differences among aging transgender adults and a general population of cisgender adults. Without comparative data on the health of aging transgender and cisgender subpopulations, it is difficult to know which subgroups are in greatest need of public health and policy interventions.</p><p>Recent methodological advances have enabled the use of claims databases to study the health of transgender populations. Blosnich et&#160;al. (2013) innovatively used transgender-specific International Classification of Diseases, Ninth Edition (ICD-9) diagnosis codes (e.g., Gender Identity Disorder (GID)) to identify transgender veterans using national Veteran Health Administration data (<xref rid="B14" ref-type="bibr">14</xref>). Proctor and colleagues later followed by applying transgender-related ICD-9 diagnosis codes to identify age- and disability-entitled transgender Medicare beneficiaries (<xref rid="B33" ref-type="bibr">33</xref>). Using the same approach as Proctor et&#160;al., Dragon and colleagues found that, compared to cisgender Medicare recipients receiving care in 2015, a higher proportion of transgender beneficiaries receiving care during the sample year had been diagnosed with several major health conditions, including asthma, autism spectrum disorder, chronic obstructive pulmonary disease, depression, hepatitis, HIV, schizophrenia, and substance use disorders (<xref rid="B30" ref-type="bibr">30</xref>). Building on the work of Proctor and Dragon, Progovac and colleagues examined disparities between transgender and cisgender Medicare beneficiaries receiving care between 2009 and 2014 (<xref rid="B31" ref-type="bibr">31</xref>). They found that older and disabled transgender Medicare beneficiaries had more diagnoses for chronic health conditions than their cisgender counterparts (<xref rid="B31" ref-type="bibr">31</xref>). Notably, however, none of these studies examined health diagnoses disparities by gender subgroup (trans feminine, trans masculine, cisgender male, cisgender female), despite prior survey-based research showing substantial within and between gender group variations in mental and physical health conditions (<xref rid="B2" ref-type="bibr">2</xref>, <xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B10" ref-type="bibr">10</xref>, <xref rid="B11" ref-type="bibr">11</xref>, <xref rid="B34" ref-type="bibr">34</xref>, <xref rid="B35" ref-type="bibr">35</xref>).</p><p>Our team has advanced algorithms identifying transgender beneficiaries in claims data and inferring their gender (<xref rid="B12" ref-type="bibr">12</xref>, <xref rid="B13" ref-type="bibr">13</xref>, <xref rid="B36" ref-type="bibr">36</xref>). Using commercial insurance data from 2001-2019, we adapted a method developed by Jasuja and colleagues (<xref rid="B13" ref-type="bibr">13</xref>) that used diagnosis, procedure, and pharmacy claim codes to identify individuals with one or more transgender-related diagnoses or Endocrine Disorder Not Otherwise Specified [Endocrine NOS] in conjunction with prescriptions for gender-affirming hormones (e.g., estrogen, testosterone) or gender-affirming procedures (e.g., phalloplasty, vaginoplasty) to identify 38,598 transgender adults. We furthered the algorithm using an approach developed by Yee, Lind, &amp; Downing (<xref rid="B36" ref-type="bibr">36</xref>) for Oregon Medicaid recipients to improve our ability to categorize transgender samples by inferred gender.<xref rid="fn1" ref-type="fn">
<sup>1</sup>
</xref> Specifically, we used a hierarchical approach to examine beneficiaries&#8217; history of gender-affirming and reproductive anatomy-specific<xref rid="fn2" ref-type="fn">
<sup>2</sup>
</xref> procedures (e.g., prostate-related procedures, hysterectomy), diagnoses, and pharmacy claims for gender-affirming hormones to categorize the sample based on inferred gender identity:<xref rid="fn3" ref-type="fn">
<sup>3</sup>
</xref> trans masculine/nonbinary (TMN) or trans feminine/nonbinary (TFN) (<xref rid="B12" ref-type="bibr">12</xref>).<xref rid="fn4" ref-type="fn">
<sup>4</sup>
</xref> By including reproductive anatomy-specific procedures and diagnoses in combination with gender-affirming care, we were able to infer the gender of 76% of the sample (50% TMN; 26% TFN), which represented a notable improvement from prior approaches (<xref rid="B13" ref-type="bibr">13</xref>).</p><p>When we applied our modified algorithm to study the health of younger, commercially-insured transgender individuals (<xref rid="B12" ref-type="bibr">12</xref>), we found that relative to TMN people, TFN people had significantly higher predicted probabilities of most health condition diagnoses, including HIV, atherosclerotic cardiovascular disorder, myocardial infarction, alcohol use disorder, and substance use disorder (<xref rid="B4" ref-type="bibr">4</xref>). In contrast, TMN individuals had significantly higher predicted probabilities of diagnosed post-traumatic stress disorder and depression than TFN people. While our prior research provides insights into within-group gender-related disparities in health diagnoses among commercially-insured adults aged 18 and over, it is unknown whether these patterns are similar among aging transgender adults aged 65 and older. To more fully understand the health of aging transgender adults, research is needed to explore within- and between-group gender differences in health diagnoses among aging transgender adults, overall and relative to their cisgender counterparts. As the largest insurer of U.S adults aged 65 and older (<xref rid="B37" ref-type="bibr">37</xref>), Medicare is the ideal data source to utilize to document within- and between-group disparities in health diagnoses for aging transgender and cisgender adults.</p><p>Building on prior work (<xref rid="B13" ref-type="bibr">13</xref>, <xref rid="B31" ref-type="bibr">31</xref>, <xref rid="B36" ref-type="bibr">36</xref>), in the present study, we sought to apply our claims-based method (<xref rid="B12" ref-type="bibr">12</xref>) to identify transgender and cisgender samples in Medicare data, stratify the samples by gender, and explore within- and between-group gender differences in health diagnoses among aging transgender and cisgender Medicare beneficiaries. Findings from this national study can help identify health diagnosis disparities among aging Medicare beneficiaries and the subgroups in greatest need of tailored interventions to prevent and treat adverse health outcomes.</p></sec><sec sec-type="materials|methods" id="s2"><title>Materials and methods</title><sec id="s2_1"><title>Study design/data source</title><p>We conducted a retrospective cross-sectional analysis to identify transgender adults, stratify them into inferred gender subgroups, and compare these groups to cisgender people. Fee-for-service Medicare data were accessed through the Virtual Data Resource Center (VRDC) maintained by the Centers for Medicare &amp; Medicaid Services (CMS) through a data use agreement (DUA 52772). We queried the Medicare Master Beneficiary Summary File and final paid claims for inpatient, physician, and other suppliers, and prescription services from 2008 to 2017.</p></sec><sec id="s2_2"><title>Identifying transgender individuals</title><p>To identify transgender individuals, we adapted our algorithm (<xref rid="B12" ref-type="bibr">12</xref>) developed with commercial insurance claims for Medicare. These methods and the corresponding codes used to identify the transgender sample are described in detail elsewhere (<xref rid="B12" ref-type="bibr">12</xref>, <xref rid="B13" ref-type="bibr">13</xref>). Briefly, we included any person with a transgender-related diagnosis (e.g., GID); transgender-conclusive procedures (e.g., &#8220;operations for sex transformation, not elsewhere classified&#8221;); a diagnosis of endocrine NOS in conjunction with a transgender-suggestive procedure or gender-affirming hormone prescription (<xref rid="SF1" ref-type="supplementary-material">
<bold>Supplementary Figure A</bold>
</xref>).</p></sec><sec id="s2_3"><title>Stratifying the transgender sample by inferred gender</title><p>We subsequently applied a previously-developed stepwise approach (<xref rid="B12" ref-type="bibr">12</xref>) to categorize the inferred gender of the transgender sample (<xref rid="SF2" ref-type="supplementary-material">
<bold>Supplementary Figure B</bold>
</xref>). As described in detail elsewhere (<xref rid="B12" ref-type="bibr">12</xref>), briefly, we first classified the inferred gender of transgender individuals based on the presence of claims for gender-affirming genital surgeries (e.g., &#8220;vaginal construction,&#8221; &#8220;construction of penis&#8221;). Then, within the remaining sample, we categorized the sample by gender if they had certain types of highly specific and highly sensitive reproductive anatomy-specific care and diagnoses (e.g., hysterectomy, pregnancy, prostate cyst, prostate screening). Next, we categorized individuals according to their receipt of gender-affirming hormones or procedures. Finally, using the remaining sample, individuals who had other reproductive anatomy-related diagnoses or procedures (e.g., vulvectomy for TMN or testicular hyperfunction for TFN) were categorized by inferred gender. Individuals who had not yet been assigned a gender category or those with conflicting codes at the final step remained unclassified. The unclassified group was comprised of people with a transgender-related diagnosis code (e.g., GID, transsexualism) and no gender-affirming hormones or procedures or reproductive-anatomy-related care or who had conflicting codes.</p></sec><sec id="s2_4"><title>Eligibility criteria for cisgender comparison cohort</title><p>After identifying the transgender cohort, we selected a random 5% sample from the remaining Medicare beneficiaries, whom we refer to here and going forth as cisgender. The sex of the beneficiaries classified as cisgender was taken from the Master Beneficiary Summary File. Because identification of the transgender cohort relied on engagement in care, we limited the cisgender cohort to beneficiaries who had at least one Part A, B, or D claim between 2008 and 2017. We excluded cisgender beneficiaries with missing data on sex and/or date of birth (about 5% of the sample).</p></sec><sec id="s2_5"><title>Measures</title><p>
<italic toggle="yes">Sociodemographics</italic>. Age was categorized as 65-&lt;70; 70-74; 75-79, 80-84, 85+. Race and ethnicity were categorized as Asian (non-Hispanic), Black (non-Hispanic), Hispanic, White (non-Hispanic), another race/ethnicity (non-Hispanic), or unknown. US Census regions included Northeast, Midwest, South, West, and Unknown. Since all Medicare beneficiaries receive fee-for-service (FFS) coverage and some may elect to pay for supplemental Part D prescription coverage, we created separate continuous months of insurance coverage variables for individuals with FFS coverage only and those with FFS plus Part D coverage.</p><p>
<italic toggle="yes">Health Condition Diagnoses.</italic> We used the CMS Chronic Condition Warehouse to identify diagnoses for 25 health conditions (<xref rid="B38" ref-type="bibr">38</xref>). We grouped the health conditions diagnoses as follows: cancer (breast, colorectal, endometrial, lung, prostate); heart, lung, &amp; kidney conditions (asthma, chronic kidney disease, chronic obstructive pulmonary disease [COPD], cardiac arrhythmia, congestive heart failure, coronary artery disease, hyperlipemia, hypertension, stroke); infectious diseases (hepatitis, HIV/AIDS); other health conditions (arthritis, diabetes, osteoporosis); mental or cognitive illness (dementia, depression, schizophrenia); and substance use disorders (alcohol, drug, tobacco use).</p></sec><sec id="s2_6"><title>Data analysis</title><p>Since Medicare data include individuals who qualify for coverage based on age (i.e., 65 or older) and disability, and the current analysis focuses on the health of aging individuals, we restricted the transgender and cisgender samples to those eligible for Medicare based on age at enrollment. We then descriptively analyzed demographic characteristics and used &#967;2 tests and t-tests to assess between-group (transgender vs. cisgender) and within-group differences (e.g., TMN vs. TFN) in sociodemographics (p&lt;0.05). Next, we estimated the crude prevalence of each condition stratified by all gender subgroups. Since the distribution of sociodemographic characteristics varied by gender subgroup (TFN vs. TMN, cisgender male vs. cisgender female), we fit logistic regression models predicting the log odds of each condition while controlling for age at enrollment, race/ethnicity, months of enrollment, and Census region. To facilitate within- and between-group comparisons, we obtained the predicted probability of each condition for each of the 4 gender subgroups that could be classified (TFN people, TMN people, cisgender males, cisgender females), holding covariates at their means. Means differences in the predicted probabilities were also assessed (p&lt;0.05). All analyses were conducted using SAS 9.4 (SAS Institute, Cary, NC).</p></sec><sec id="s2_7"><title>Reporting and discussion of results</title><p>In reporting and discussing the results for the transgender and cisgender subgroups, we describe within- and between-group gender differences in the crude prevalence and means of the demographic characteristics and the predicted probabilities of the health diagnoses. For demographics, we report and discuss differences between transgender and cisgender people overall, as well as within-group differences among transgender (TFN vs. TMN) and cisgender (male vs. female) subgroups. For the predicted probabilities, we report all diagnoses and discuss the diagnoses with the widest within- and between-group disparities.</p><p>For differences in the predicted probabilities, we first discuss between-group differences in individuals presumed to have been assigned the same sex at birth (i.e., cisgender males and TFN people; and cisgender females and TMN people). Although referring to a transgender person by their assigned birth sex is not affirming or appropriate, these comparisons were made because, on a population level, cisgender and transgender people assigned the same sex at birth are typically born with similar reproductive anatomy and endogenous hormones that could impact their risk of developing specific health conditions. People assigned the same sex at birth may also be more likely to experience similar social or developmental influences in childhood and adolescence that could influence their tendency to engage in behaviors that might increase or decrease their risk of developing specific conditions.</p><p>We also discuss between-group differences between TFN people and cisgender females and between TMN people and cisgender males. We make these comparisons as the use of gender-affirming hormones and procedures may result in TFN people having hormone exposure levels and anatomies that are more closely aligned with cisgender females than cisgender males, and TMN individuals may come to have hormone exposure levels and anatomies that are more similar to cisgender males than cisgender females.</p><p>Finally, making these comparisons in the results and discussion enables us to engage with the breadth of medical, public health, psychological, sociological, and other literature documenting the prevalence of and mechanisms underlying health diagnosis disparities between individuals who were assigned the same birth sex or who share similar gender identities or expressions. Specific limitations of this approach are denoted in the discussion.</p></sec></sec><sec sec-type="results" id="s3"><title>Results</title><sec id="s3_1"><title>Demographic characteristics</title><p>
<xref rid="T1" ref-type="table">
<bold>Table&#160;1</bold>
</xref> summarizes the demographic characteristics of the sample. We identified 9,975 transgender FFS beneficiaries who qualified for Medicare based on age. Overall, 4,198 (41.1%) were categorized as TFN, 2,762 (27.7%) as TMN, and the gender could not be inferred and classified for 3,015 transgender beneficiaries (30.2% unclassified). Of the 2,961,636 cisgender individuals included in the comparison sample, 1,294,690 (43.7%) were male, and 1,666,946 (56.3%) were female.</p><table-wrap position="float" id="T1" orientation="portrait"><label>Table&#160;1</label><caption><p>Demographics at enrollment among age-entitled beneficiaries stratified by inferred gender in a national Medicare population, 2008-2017.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="bottom" align="center" rowspan="3" colspan="1"/><th valign="bottom" colspan="4" align="center" rowspan="1">TOTAL</th><th valign="bottom" align="center" rowspan="3" colspan="1"/><th valign="bottom" colspan="6" align="center" rowspan="1">TRANSGENDER</th><th valign="bottom" align="center" rowspan="3" colspan="1"/><th valign="bottom" colspan="4" align="center" rowspan="1">CISGENDER</th><th valign="bottom" align="center" rowspan="3" colspan="1"/></tr><tr><th valign="bottom" colspan="4" align="center" rowspan="1">N=2,971,611</th><th valign="bottom" colspan="6" align="center" rowspan="1">N=9,975</th><th valign="bottom" colspan="4" align="center" rowspan="1">N=2,961,636</th></tr><tr><th valign="bottom" colspan="2" align="center" rowspan="1">Transgender N=9,975</th><th valign="bottom" colspan="2" align="center" rowspan="1">Cisgender N=2,961,636</th><th valign="bottom" colspan="2" align="center" rowspan="1">TFN N=4,198</th><th valign="bottom" colspan="2" align="center" rowspan="1">TMN N=2,762</th><th valign="bottom" colspan="2" align="center" rowspan="1">Unclassified N=3,015</th><th valign="bottom" colspan="2" align="center" rowspan="1">Male N=1,294,690</th><th valign="bottom" colspan="2" align="center" rowspan="1">Female N=1,666,946</th></tr><tr><th valign="bottom" align="left" rowspan="1" colspan="1">Age at Enrollment (y)</th><th valign="bottom" align="center" rowspan="1" colspan="1">N</th><th valign="bottom" align="center" rowspan="1" colspan="1">%</th><th valign="bottom" align="center" rowspan="1" colspan="1">N</th><th valign="bottom" align="center" rowspan="1" colspan="1">%</th><th valign="bottom" align="center" rowspan="1" colspan="1">P-Value</th><th valign="bottom" align="center" rowspan="1" colspan="1">N</th><th valign="bottom" align="center" rowspan="1" colspan="1">%</th><th valign="bottom" align="center" rowspan="1" colspan="1">N</th><th valign="bottom" align="center" rowspan="1" colspan="1">%</th><th valign="bottom" align="center" rowspan="1" colspan="1">N</th><th valign="bottom" align="center" rowspan="1" colspan="1">%</th><th valign="bottom" align="center" rowspan="1" colspan="1">P-value</th><th valign="bottom" align="center" rowspan="1" colspan="1">N</th><th valign="bottom" align="center" rowspan="1" colspan="1">%</th><th valign="bottom" align="center" rowspan="1" colspan="1">N</th><th valign="bottom" align="center" rowspan="1" colspan="1">$</th><th valign="bottom" align="center" rowspan="1" colspan="1">P-Value</th></tr></thead><tbody><tr><td valign="bottom" align="left" rowspan="1" colspan="1">65-&lt;70</td><td valign="bottom" align="center" rowspan="1" colspan="1">6,003</td><td valign="bottom" align="center" rowspan="1" colspan="1">60.2</td><td valign="bottom" align="center" rowspan="1" colspan="1">1,604,745</td><td valign="bottom" align="center" rowspan="1" colspan="1">54.2</td><td valign="bottom" align="center" rowspan="1" colspan="1">&lt;0.0001</td><td valign="bottom" align="center" rowspan="1" colspan="1">2,643</td><td valign="bottom" align="center" rowspan="1" colspan="1">63.0</td><td valign="bottom" align="center" rowspan="1" colspan="1">1,583</td><td valign="bottom" align="center" rowspan="1" colspan="1">57.3</td><td valign="bottom" align="center" rowspan="1" colspan="1">1,777</td><td valign="bottom" align="center" rowspan="1" colspan="1">58.9</td><td valign="bottom" align="center" rowspan="1" colspan="1">&lt;0.0001</td><td valign="bottom" align="center" rowspan="1" colspan="1">730,794</td><td valign="bottom" align="center" rowspan="1" colspan="1">56.4</td><td valign="bottom" align="center" rowspan="1" colspan="1">873,951</td><td valign="bottom" align="center" rowspan="1" colspan="1">52.4</td><td valign="bottom" align="center" rowspan="1" colspan="1">&lt;0.0001</td></tr><tr><td valign="bottom" align="left" rowspan="1" colspan="1">70-74</td><td valign="bottom" align="center" rowspan="1" colspan="1">1,565</td><td valign="bottom" align="center" rowspan="1" colspan="1">15.7</td><td valign="bottom" align="center" rowspan="1" colspan="1">464,378</td><td valign="bottom" align="center" rowspan="1" colspan="1">15.7</td><td valign="bottom" align="center" rowspan="1" colspan="1"/><td valign="bottom" align="center" rowspan="1" colspan="1">684</td><td valign="bottom" align="center" rowspan="1" colspan="1">16.3</td><td valign="bottom" align="center" rowspan="1" colspan="1">502</td><td valign="bottom" align="center" rowspan="1" colspan="1">18.2</td><td valign="bottom" align="center" rowspan="1" colspan="1">379</td><td valign="bottom" align="center" rowspan="1" colspan="1">12.6</td><td valign="bottom" align="center" rowspan="1" colspan="1"/><td valign="bottom" align="center" rowspan="1" colspan="1">215,803</td><td valign="bottom" align="center" rowspan="1" colspan="1">16.7</td><td valign="bottom" align="center" rowspan="1" colspan="1">248,575</td><td valign="bottom" align="center" rowspan="1" colspan="1">14.9</td><td valign="bottom" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="bottom" align="left" rowspan="1" colspan="1">75-79</td><td valign="bottom" align="center" rowspan="1" colspan="1">1,132</td><td valign="bottom" align="center" rowspan="1" colspan="1">11.3</td><td valign="bottom" align="center" rowspan="1" colspan="1">362,645</td><td valign="bottom" align="center" rowspan="1" colspan="1">12.2</td><td valign="bottom" align="center" rowspan="1" colspan="1"/><td valign="bottom" align="center" rowspan="1" colspan="1">481</td><td valign="bottom" align="center" rowspan="1" colspan="1">11.5</td><td valign="bottom" align="center" rowspan="1" colspan="1">333</td><td valign="bottom" align="center" rowspan="1" colspan="1">12.1</td><td valign="bottom" align="center" rowspan="1" colspan="1">318</td><td valign="bottom" align="center" rowspan="1" colspan="1">10.5</td><td valign="bottom" align="center" rowspan="1" colspan="1"/><td valign="bottom" align="center" rowspan="1" colspan="1">157,583</td><td valign="bottom" align="center" rowspan="1" colspan="1">12.2</td><td valign="bottom" align="center" rowspan="1" colspan="1">205,062</td><td valign="bottom" align="center" rowspan="1" colspan="1">12.3</td><td valign="bottom" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="bottom" align="left" rowspan="1" colspan="1">80-84</td><td valign="bottom" align="center" rowspan="1" colspan="1">791</td><td valign="bottom" align="center" rowspan="1" colspan="1">7.9</td><td valign="bottom" align="center" rowspan="1" colspan="1">277,783</td><td valign="bottom" align="center" rowspan="1" colspan="1">9.4</td><td valign="bottom" align="center" rowspan="1" colspan="1"/><td valign="bottom" align="center" rowspan="1" colspan="1">276</td><td valign="bottom" align="center" rowspan="1" colspan="1">6.6</td><td valign="bottom" align="center" rowspan="1" colspan="1">233</td><td valign="bottom" align="center" rowspan="1" colspan="1">8.4</td><td valign="bottom" align="center" rowspan="1" colspan="1">282</td><td valign="bottom" align="center" rowspan="1" colspan="1">9.4</td><td valign="bottom" align="center" rowspan="1" colspan="1"/><td valign="bottom" align="center" rowspan="1" colspan="1">109,575</td><td valign="bottom" align="center" rowspan="1" colspan="1">8.5</td><td valign="bottom" align="center" rowspan="1" colspan="1">168,208</td><td valign="bottom" align="center" rowspan="1" colspan="1">10.1</td><td valign="bottom" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="bottom" align="left" rowspan="1" colspan="1">&gt;= 85</td><td valign="bottom" align="center" rowspan="1" colspan="1">484</td><td valign="bottom" align="center" rowspan="1" colspan="1">4.9</td><td valign="bottom" align="center" rowspan="1" colspan="1">252,085</td><td valign="bottom" align="center" rowspan="1" colspan="1">8.5</td><td valign="bottom" align="center" rowspan="1" colspan="1"/><td valign="bottom" align="center" rowspan="1" colspan="1">114</td><td valign="bottom" align="center" rowspan="1" colspan="1">2.7</td><td valign="bottom" align="center" rowspan="1" colspan="1">111</td><td valign="bottom" align="center" rowspan="1" colspan="1">4.0</td><td valign="bottom" align="center" rowspan="1" colspan="1">259</td><td valign="bottom" align="center" rowspan="1" colspan="1">8.6</td><td valign="bottom" align="center" rowspan="1" colspan="1"/><td valign="bottom" align="center" rowspan="1" colspan="1">80,935</td><td valign="bottom" align="center" rowspan="1" colspan="1">6.3</td><td valign="bottom" align="center" rowspan="1" colspan="1">171,150</td><td valign="bottom" align="center" rowspan="1" colspan="1">10.3</td><td valign="bottom" align="center" rowspan="1" colspan="1"/></tr><tr><th valign="bottom" colspan="18" align="left" rowspan="1">Race/ethnicity</th></tr><tr><td valign="bottom" align="left" rowspan="1" colspan="1">Asian</td><td valign="bottom" align="center" rowspan="1" colspan="1">237</td><td valign="bottom" align="center" rowspan="1" colspan="1">2.4</td><td valign="bottom" align="center" rowspan="1" colspan="1">92,031</td><td valign="bottom" align="center" rowspan="1" colspan="1">3.1</td><td valign="bottom" align="center" rowspan="1" colspan="1">&lt;0.0001</td><td valign="bottom" align="center" rowspan="1" colspan="1">95</td><td valign="bottom" align="center" rowspan="1" colspan="1">2.3</td><td valign="bottom" align="center" rowspan="1" colspan="1">63</td><td valign="bottom" align="center" rowspan="1" colspan="1">2.3</td><td valign="bottom" align="center" rowspan="1" colspan="1">79</td><td valign="bottom" align="center" rowspan="1" colspan="1">2.6</td><td valign="bottom" align="center" rowspan="1" colspan="1">0.001</td><td valign="bottom" align="center" rowspan="1" colspan="1">40,329</td><td valign="bottom" align="center" rowspan="1" colspan="1">3.1</td><td valign="bottom" align="center" rowspan="1" colspan="1">51,702</td><td valign="bottom" align="center" rowspan="1" colspan="1">3.1</td><td valign="bottom" align="center" rowspan="1" colspan="1">&lt;0.0001</td></tr><tr><td valign="bottom" align="left" rowspan="1" colspan="1">Black</td><td valign="bottom" align="center" rowspan="1" colspan="1">655</td><td valign="bottom" align="center" rowspan="1" colspan="1">6.6</td><td valign="bottom" align="center" rowspan="1" colspan="1">239,491</td><td valign="bottom" align="center" rowspan="1" colspan="1">8.1</td><td valign="bottom" align="center" rowspan="1" colspan="1"/><td valign="bottom" align="center" rowspan="1" colspan="1">234</td><td valign="bottom" align="center" rowspan="1" colspan="1">5.6</td><td valign="bottom" align="center" rowspan="1" colspan="1">197</td><td valign="bottom" align="center" rowspan="1" colspan="1">7.1</td><td valign="bottom" align="center" rowspan="1" colspan="1">224</td><td valign="bottom" align="center" rowspan="1" colspan="1">7.4</td><td valign="bottom" align="center" rowspan="1" colspan="1"/><td valign="bottom" align="center" rowspan="1" colspan="1">95,361</td><td valign="bottom" align="center" rowspan="1" colspan="1">7.4</td><td valign="bottom" align="center" rowspan="1" colspan="1">144,130</td><td valign="bottom" align="center" rowspan="1" colspan="1">8.6</td><td valign="bottom" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="bottom" align="left" rowspan="1" colspan="1">Hispanic</td><td valign="bottom" align="center" rowspan="1" colspan="1">537</td><td valign="bottom" align="center" rowspan="1" colspan="1">5.4</td><td valign="bottom" align="center" rowspan="1" colspan="1">222,517</td><td valign="bottom" align="center" rowspan="1" colspan="1">7.5</td><td valign="bottom" align="center" rowspan="1" colspan="1"/><td valign="bottom" align="center" rowspan="1" colspan="1">231</td><td valign="bottom" align="center" rowspan="1" colspan="1">5.5</td><td valign="bottom" align="center" rowspan="1" colspan="1">136</td><td valign="bottom" align="center" rowspan="1" colspan="1">4.9</td><td valign="bottom" align="center" rowspan="1" colspan="1">170</td><td valign="bottom" align="center" rowspan="1" colspan="1">5.6</td><td valign="bottom" align="center" rowspan="1" colspan="1"/><td valign="bottom" align="center" rowspan="1" colspan="1">96,718</td><td valign="bottom" align="center" rowspan="1" colspan="1">7.5</td><td valign="bottom" align="center" rowspan="1" colspan="1">125,799</td><td valign="bottom" align="center" rowspan="1" colspan="1">7.5</td><td valign="bottom" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="bottom" align="left" rowspan="1" colspan="1">White</td><td valign="bottom" align="center" rowspan="1" colspan="1">8,303</td><td valign="bottom" align="center" rowspan="1" colspan="1">83.2</td><td valign="bottom" align="center" rowspan="1" colspan="1">2,340,841</td><td valign="bottom" align="center" rowspan="1" colspan="1">79.0</td><td valign="bottom" align="center" rowspan="1" colspan="1"/><td valign="bottom" align="center" rowspan="1" colspan="1">3,524</td><td valign="bottom" align="center" rowspan="1" colspan="1">83.9</td><td valign="bottom" align="center" rowspan="1" colspan="1">2,322</td><td valign="bottom" align="center" rowspan="1" colspan="1">84.1</td><td valign="bottom" align="center" rowspan="1" colspan="1">2,457</td><td valign="bottom" align="center" rowspan="1" colspan="1">81.5</td><td valign="bottom" align="center" rowspan="1" colspan="1"/><td valign="bottom" align="center" rowspan="1" colspan="1">1,026,070</td><td valign="bottom" align="center" rowspan="1" colspan="1">79.3</td><td valign="bottom" align="center" rowspan="1" colspan="1">1,314,771</td><td valign="bottom" align="center" rowspan="1" colspan="1">78.9</td><td valign="bottom" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="bottom" align="left" rowspan="1" colspan="1">Another race/ ethnicity</td><td valign="bottom" align="center" rowspan="1" colspan="1">105</td><td valign="bottom" align="center" rowspan="1" colspan="1">1.1</td><td valign="bottom" align="center" rowspan="1" colspan="1">32,060</td><td valign="bottom" align="center" rowspan="1" colspan="1">1.1</td><td valign="bottom" align="center" rowspan="1" colspan="1"/><td valign="bottom" align="center" rowspan="1" colspan="1">43</td><td valign="bottom" align="center" rowspan="1" colspan="1">1.0</td><td valign="bottom" align="center" rowspan="1" colspan="1">21</td><td valign="bottom" align="center" rowspan="1" colspan="1">0.8</td><td valign="bottom" align="center" rowspan="1" colspan="1">41</td><td valign="bottom" align="center" rowspan="1" colspan="1">1.4</td><td valign="bottom" align="center" rowspan="1" colspan="1"/><td valign="bottom" align="center" rowspan="1" colspan="1">14,364</td><td valign="bottom" align="center" rowspan="1" colspan="1">1.1</td><td valign="bottom" align="center" rowspan="1" colspan="1">17,696</td><td valign="bottom" align="center" rowspan="1" colspan="1">1.1</td><td valign="bottom" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="bottom" align="left" rowspan="1" colspan="1">Unknown</td><td valign="bottom" align="center" rowspan="1" colspan="1">138</td><td valign="bottom" align="center" rowspan="1" colspan="1">1.4</td><td valign="bottom" align="center" rowspan="1" colspan="1">34,696</td><td valign="bottom" align="center" rowspan="1" colspan="1">1.2</td><td valign="bottom" align="center" rowspan="1" colspan="1"/><td valign="bottom" align="center" rowspan="1" colspan="1">71</td><td valign="bottom" align="center" rowspan="1" colspan="1">1.7</td><td valign="bottom" align="center" rowspan="1" colspan="1">23</td><td valign="bottom" align="center" rowspan="1" colspan="1">0.8</td><td valign="bottom" align="center" rowspan="1" colspan="1">44</td><td valign="bottom" align="center" rowspan="1" colspan="1">1.5</td><td valign="bottom" align="center" rowspan="1" colspan="1"/><td valign="bottom" align="center" rowspan="1" colspan="1">21,848</td><td valign="bottom" align="center" rowspan="1" colspan="1">1.7</td><td valign="bottom" align="center" rowspan="1" colspan="1">12,848</td><td valign="bottom" align="center" rowspan="1" colspan="1">0.8</td><td valign="bottom" align="center" rowspan="1" colspan="1"/></tr><tr><th valign="bottom" colspan="18" align="left" rowspan="1">Census Region</th></tr><tr><td valign="bottom" align="left" rowspan="1" colspan="1">Northeast</td><td valign="bottom" align="center" rowspan="1" colspan="1">2,264</td><td valign="bottom" align="center" rowspan="1" colspan="1">22.7</td><td valign="bottom" align="center" rowspan="1" colspan="1">557,113</td><td valign="bottom" align="center" rowspan="1" colspan="1">18.8</td><td valign="bottom" align="center" rowspan="1" colspan="1">&lt;0.0001</td><td valign="bottom" align="center" rowspan="1" colspan="1">947</td><td valign="bottom" align="center" rowspan="1" colspan="1">22.6</td><td valign="bottom" align="center" rowspan="1" colspan="1">628</td><td valign="bottom" align="center" rowspan="1" colspan="1">22.7</td><td valign="bottom" align="center" rowspan="1" colspan="1">689</td><td valign="bottom" align="center" rowspan="1" colspan="1">22.9</td><td valign="bottom" align="center" rowspan="1" colspan="1">&lt;0.0001</td><td valign="bottom" align="center" rowspan="1" colspan="1">237,772</td><td valign="bottom" align="center" rowspan="1" colspan="1">18.4</td><td valign="bottom" align="center" rowspan="1" colspan="1">319,341</td><td valign="bottom" align="center" rowspan="1" colspan="1">19.2</td><td valign="bottom" align="center" rowspan="1" colspan="1">&lt;0.0001</td></tr><tr><td valign="bottom" align="left" rowspan="1" colspan="1">Midwest</td><td valign="bottom" align="center" rowspan="1" colspan="1">1,962</td><td valign="bottom" align="center" rowspan="1" colspan="1">19.7</td><td valign="bottom" align="center" rowspan="1" colspan="1">669,506</td><td valign="bottom" align="center" rowspan="1" colspan="1">22.6</td><td valign="bottom" align="center" rowspan="1" colspan="1"/><td valign="bottom" align="center" rowspan="1" colspan="1">788</td><td valign="bottom" align="center" rowspan="1" colspan="1">18.8</td><td valign="bottom" align="center" rowspan="1" colspan="1">521</td><td valign="bottom" align="center" rowspan="1" colspan="1">18.9</td><td valign="bottom" align="center" rowspan="1" colspan="1">653</td><td valign="bottom" align="center" rowspan="1" colspan="1">21.7</td><td valign="bottom" align="center" rowspan="1" colspan="1"/><td valign="bottom" align="center" rowspan="1" colspan="1">292,635</td><td valign="bottom" align="center" rowspan="1" colspan="1">22.6</td><td valign="bottom" align="center" rowspan="1" colspan="1">376,871</td><td valign="bottom" align="center" rowspan="1" colspan="1">22.6</td><td valign="bottom" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="bottom" align="left" rowspan="1" colspan="1">South</td><td valign="bottom" align="center" rowspan="1" colspan="1">3,252</td><td valign="bottom" align="center" rowspan="1" colspan="1">32.6</td><td valign="bottom" align="center" rowspan="1" colspan="1">1,071,084</td><td valign="bottom" align="center" rowspan="1" colspan="1">36.2</td><td valign="bottom" align="center" rowspan="1" colspan="1"/><td valign="bottom" align="center" rowspan="1" colspan="1">1,388</td><td valign="bottom" align="center" rowspan="1" colspan="1">33.1</td><td valign="bottom" align="center" rowspan="1" colspan="1">997</td><td valign="bottom" align="center" rowspan="1" colspan="1">36.1</td><td valign="bottom" align="center" rowspan="1" colspan="1">867</td><td valign="bottom" align="center" rowspan="1" colspan="1">28.8</td><td valign="bottom" align="center" rowspan="1" colspan="1"/><td valign="bottom" align="center" rowspan="1" colspan="1">467,104</td><td valign="bottom" align="center" rowspan="1" colspan="1">36.1</td><td valign="bottom" align="center" rowspan="1" colspan="1">603,980</td><td valign="bottom" align="center" rowspan="1" colspan="1">36.2</td><td valign="bottom" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="bottom" align="left" rowspan="1" colspan="1">West</td><td valign="bottom" align="center" rowspan="1" colspan="1">2,468</td><td valign="bottom" align="center" rowspan="1" colspan="1">24.7</td><td valign="bottom" align="center" rowspan="1" colspan="1">628,446</td><td valign="bottom" align="center" rowspan="1" colspan="1">21.2</td><td valign="bottom" align="center" rowspan="1" colspan="1"/><td valign="bottom" align="center" rowspan="1" colspan="1">1,060</td><td valign="bottom" align="center" rowspan="1" colspan="1">25.3</td><td valign="bottom" align="center" rowspan="1" colspan="1">611</td><td valign="bottom" align="center" rowspan="1" colspan="1">22.1</td><td valign="bottom" align="center" rowspan="1" colspan="1">797</td><td valign="bottom" align="center" rowspan="1" colspan="1">26.4</td><td valign="bottom" align="center" rowspan="1" colspan="1"/><td valign="bottom" align="center" rowspan="1" colspan="1">281,716</td><td valign="bottom" align="center" rowspan="1" colspan="1">21.8</td><td valign="bottom" align="center" rowspan="1" colspan="1">346,730</td><td valign="bottom" align="center" rowspan="1" colspan="1">20.8</td><td valign="bottom" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="bottom" align="left" rowspan="1" colspan="1">Unknown</td><td valign="bottom" align="center" rowspan="1" colspan="1">---</td><td valign="bottom" align="center" rowspan="1" colspan="1">---</td><td valign="bottom" align="center" rowspan="1" colspan="1">35,487</td><td valign="bottom" align="center" rowspan="1" colspan="1">1.2</td><td valign="bottom" align="center" rowspan="1" colspan="1"/><td valign="bottom" align="center" rowspan="1" colspan="1">---</td><td valign="bottom" align="center" rowspan="1" colspan="1">---</td><td valign="bottom" align="center" rowspan="1" colspan="1">---</td><td valign="bottom" align="center" rowspan="1" colspan="1">---</td><td valign="bottom" align="center" rowspan="1" colspan="1">---</td><td valign="bottom" align="center" rowspan="1" colspan="1">---</td><td valign="bottom" align="center" rowspan="1" colspan="1"/><td valign="bottom" align="center" rowspan="1" colspan="1">15,463</td><td valign="bottom" align="center" rowspan="1" colspan="1">1.2</td><td valign="bottom" align="center" rowspan="1" colspan="1">20,024</td><td valign="bottom" align="center" rowspan="1" colspan="1">1.2</td><td valign="bottom" align="center" rowspan="1" colspan="1"/></tr><tr><th valign="bottom" align="left" rowspan="1" colspan="1">Months of Coverage</th><th valign="bottom" align="left" rowspan="1" colspan="1">Mean</th><th valign="bottom" align="left" rowspan="1" colspan="1">SD</th><th valign="bottom" align="left" rowspan="1" colspan="1">Mean</th><th valign="bottom" align="left" rowspan="1" colspan="1">SD</th><th valign="bottom" align="left" rowspan="1" colspan="1">P-Value</th><th valign="bottom" align="left" rowspan="1" colspan="1">Mean</th><th valign="bottom" align="left" rowspan="1" colspan="1">SD</th><th valign="bottom" align="left" rowspan="1" colspan="1">Mean</th><th valign="bottom" align="left" rowspan="1" colspan="1">SD</th><th valign="bottom" align="left" rowspan="1" colspan="1">Mean</th><th valign="bottom" align="left" rowspan="1" colspan="1">SD</th><th valign="bottom" align="left" rowspan="1" colspan="1">P-value</th><th valign="bottom" align="left" rowspan="1" colspan="1">Mean</th><th valign="bottom" align="left" rowspan="1" colspan="1">SD</th><th valign="bottom" align="left" rowspan="1" colspan="1">Mean</th><th valign="bottom" align="left" rowspan="1" colspan="1">SD</th><th valign="bottom" align="left" rowspan="1" colspan="1">P-Value</th></tr><tr><td valign="bottom" align="left" rowspan="1" colspan="1">Mean months of FFS Coverage</td><td valign="bottom" align="center" rowspan="1" colspan="1">76.49</td><td valign="bottom" align="center" rowspan="1" colspan="1">41.65</td><td valign="bottom" align="center" rowspan="1" colspan="1">50.74</td><td valign="bottom" align="center" rowspan="1" colspan="1">44.94</td><td valign="bottom" align="center" rowspan="1" colspan="1">&lt;0.0001</td><td valign="bottom" align="center" rowspan="1" colspan="1">79.99</td><td valign="bottom" align="center" rowspan="1" colspan="1">39.47</td><td valign="bottom" align="center" rowspan="1" colspan="1">88.32</td><td valign="bottom" align="center" rowspan="1" colspan="1">37.08</td><td valign="bottom" align="center" rowspan="1" colspan="1">60.76</td><td valign="bottom" align="center" rowspan="1" colspan="1">43.79</td><td valign="bottom" align="center" rowspan="1" colspan="1">&lt;0.0001</td><td valign="bottom" align="center" rowspan="1" colspan="1">49.34</td><td valign="bottom" align="center" rowspan="1" colspan="1">44.03</td><td valign="bottom" align="center" rowspan="1" colspan="1">51.82</td><td valign="bottom" align="center" rowspan="1" colspan="1">45.61</td><td valign="bottom" align="center" rowspan="1" colspan="1">&lt;0.0001</td></tr><tr><td valign="bottom" align="left" rowspan="1" colspan="1">Mean months of FFS + Part D Coverage</td><td valign="bottom" align="center" rowspan="1" colspan="1">50.04</td><td valign="bottom" align="center" rowspan="1" colspan="1">41.64</td><td valign="bottom" align="center" rowspan="1" colspan="1">32.47</td><td valign="bottom" align="center" rowspan="1" colspan="1">38.06</td><td valign="bottom" align="center" rowspan="1" colspan="1">&lt;0.0001</td><td valign="bottom" align="center" rowspan="1" colspan="1">50.36</td><td valign="bottom" align="center" rowspan="1" colspan="1">40.19</td><td valign="bottom" align="center" rowspan="1" colspan="1">59.53</td><td valign="bottom" align="center" rowspan="1" colspan="1">42.28</td><td valign="bottom" align="center" rowspan="1" colspan="1">40.92</td><td valign="bottom" align="center" rowspan="1" colspan="1">41.06</td><td valign="bottom" align="center" rowspan="1" colspan="1">&lt;0.001</td><td valign="bottom" align="center" rowspan="1" colspan="1">29.16</td><td valign="bottom" align="center" rowspan="1" colspan="1">35.78</td><td valign="bottom" align="center" rowspan="1" colspan="1">35.03</td><td valign="bottom" align="center" rowspan="1" colspan="1">39.54</td><td valign="bottom" align="center" rowspan="1" colspan="1">&lt;0.0001</td></tr></tbody></table><table-wrap-foot><fn><p>This Medicare sample was restricted to those age 65 and older who qualified for Medicare based on age. TFN, Trans Feminine and Nonbinary; TMN, Trans Masculine and Nonbinary. FFS, Fee for service. For categorical variables, the p-value is based on chi-square tests (X<sup>2</sup>). For continuous variables, the p-value is based on t-tests. For the transgender sample, chi-square and t-test compared differences between TFN and TMN people only. Per Center for Medicare &amp; Medicaid Services (CMS) guidelines, the number of TFN, TMN, and unclassified transgender individuals from an unknown census region are not reported as the cell sizes for one or more groups are less than 11.</p></fn></table-wrap-foot></table-wrap><p>There were significant between-group gender differences in the demographics of the samples. Overall, a higher proportion of transgender beneficiaries enrolled in Medicare at a younger age, were non-Hispanic White, and lived in the Northeast or West at enrollment compared to cisgender beneficiaries. Transgender individuals also had a significantly longer mean period of continuous enrollment relative to cisgender individuals (p&lt;.0001).</p><p>There were also significant within-group gender differences. Regarding demographic differences between TFN and TMN people, although statistically significant, there were relatively small differences between these groups with regard to race/ethnicity and region. Notably, among the transgender sample, a larger proportion of TFN people enrolled before age 70, whereas a larger proportion of the unclassified group enrolled at age 85 or older; also, on average, TMN had significantly more months of continuous enrollment than other transgender groups (p&lt;.0001). With regard to with-in-group differences for the cisgender sample, a higher proportion of cisgender males than females enrolled in Medicare before age 70, yet, on average, cisgender females had more continuous months of enrollment than cisgender males. Further, despite statistically significant differences in the distribution of race-ethnicity and geographic region, percent point differences were relatively small between cisgender males and females.</p></sec><sec id="s3_2"><title>Health condition diagnoses</title><p>The unadjusted prevalence for each diagnosis among all transgender and cisgender subgroups is presented in <xref rid="ST1" ref-type="supplementary-material">
<bold>Supplementary Table&#160;1</bold>
</xref>. <xref rid="T2" ref-type="table">
<bold>Table&#160;2</bold>
</xref> and <xref rid="f1" ref-type="fig">
<bold>Figure&#160;1</bold>
</xref> present results from the adjusted models for TMN and TFN people and cisgender males and females, and <xref rid="ST2" ref-type="supplementary-material">
<bold>Supplementary Table&#160;2</bold>
</xref> presents the mean differences in the predicted probability of each diagnosis by gender subgroup. Overall, TFN or TMN people had the highest predicted probability (herein &#8220;probability&#8221;) of every diagnosis relative to cisgender males and females. Additionally, TFN individuals had the highest probability of being diagnosed with the majority of health conditions compared to TMN people, as well as cisgender males and females.</p><table-wrap position="float" id="T2" orientation="portrait"><label>Table&#160;2</label><caption><p>Adjusted predicted probabilities of health condition diagnoses stratified by inferred gender among age-entitled transgender and cisgender Medicare beneficiaries, 2008-2017.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="bottom" align="center" rowspan="3" colspan="1"/><th valign="bottom" colspan="4" align="center" rowspan="1">TRANSGENDER</th><th valign="bottom" colspan="4" align="center" rowspan="1">CISGENDER</th></tr><tr><th valign="middle" colspan="2" align="center" rowspan="1">TFN N=4,198</th><th valign="middle" colspan="2" align="center" rowspan="1">TMN N=2,762</th><th valign="middle" colspan="2" align="center" rowspan="1">Male N=1,294,690</th><th valign="middle" colspan="2" align="center" rowspan="1">Female N=1,666,946</th></tr><tr><th valign="bottom" align="center" rowspan="1" colspan="1">%</th><th valign="bottom" align="center" rowspan="1" colspan="1">95% CI</th><th valign="bottom" align="center" rowspan="1" colspan="1">%</th><th valign="bottom" align="center" rowspan="1" colspan="1">95% CI</th><th valign="bottom" align="center" rowspan="1" colspan="1">%</th><th valign="bottom" align="center" rowspan="1" colspan="1">95% CI</th><th valign="bottom" align="center" rowspan="1" colspan="1">%</th><th valign="bottom" align="center" rowspan="1" colspan="1">95% CI</th></tr></thead><tbody><tr><th valign="middle" colspan="9" align="left" rowspan="1">CANCER</th></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">Breast</td><td valign="middle" align="center" rowspan="1" colspan="1">0.4</td><td valign="middle" align="center" rowspan="1" colspan="1">0.2-0.5</td><td valign="middle" align="center" rowspan="1" colspan="1">7.5</td><td valign="middle" align="center" rowspan="1" colspan="1">6.8-8.4</td><td valign="middle" align="center" rowspan="1" colspan="1">0.1</td><td valign="middle" align="center" rowspan="1" colspan="1">0.1-0.1</td><td valign="middle" align="center" rowspan="1" colspan="1">6.2</td><td valign="middle" align="center" rowspan="1" colspan="1">6.1-6.3</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">Colorectal</td><td valign="middle" align="center" rowspan="1" colspan="1">3.6</td><td valign="middle" align="center" rowspan="1" colspan="1">3.1-4.1</td><td valign="middle" align="center" rowspan="1" colspan="1">3.1</td><td valign="middle" align="center" rowspan="1" colspan="1">2.6-3.6</td><td valign="middle" align="center" rowspan="1" colspan="1">2.7</td><td valign="middle" align="center" rowspan="1" colspan="1">2.6-2.8</td><td valign="middle" align="center" rowspan="1" colspan="1">2.1</td><td valign="middle" align="center" rowspan="1" colspan="1">2.0-2.1</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">Endometrial</td><td valign="middle" align="center" rowspan="1" colspan="1">&#8212;</td><td valign="middle" align="center" rowspan="1" colspan="1">&#8212;</td><td valign="middle" align="center" rowspan="1" colspan="1">1.7</td><td valign="middle" align="center" rowspan="1" colspan="1">1.4-2.1</td><td valign="middle" align="center" rowspan="1" colspan="1">&#8212;</td><td valign="middle" align="center" rowspan="1" colspan="1">&#8212;</td><td valign="middle" align="center" rowspan="1" colspan="1">1.1</td><td valign="middle" align="center" rowspan="1" colspan="1">1.1-1.2</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">Lung</td><td valign="middle" align="center" rowspan="1" colspan="1">2.5</td><td valign="middle" align="center" rowspan="1" colspan="1">2.1-2.9</td><td valign="middle" align="center" rowspan="1" colspan="1">2.7</td><td valign="middle" align="center" rowspan="1" colspan="1">2.3-3.3</td><td valign="middle" align="center" rowspan="1" colspan="1">2.3</td><td valign="middle" align="center" rowspan="1" colspan="1">2.2-2.4</td><td valign="middle" align="center" rowspan="1" colspan="1">1.7</td><td valign="middle" align="center" rowspan="1" colspan="1">1.6-1.7</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">Prostate</td><td valign="middle" align="center" rowspan="1" colspan="1">11.2</td><td valign="middle" align="center" rowspan="1" colspan="1">10.4-12.1</td><td valign="middle" align="center" rowspan="1" colspan="1">&#8212;</td><td valign="middle" align="center" rowspan="1" colspan="1">&#8212;</td><td valign="middle" align="center" rowspan="1" colspan="1">10.1</td><td valign="middle" align="center" rowspan="1" colspan="1">9.9-10.3</td><td valign="middle" align="center" rowspan="1" colspan="1">&#8212;</td><td valign="middle" align="center" rowspan="1" colspan="1">&#8212;</td></tr><tr><th valign="middle" colspan="9" align="left" rowspan="1">HEART, LUNG, &amp; KIDNEY CONDITIONS</th></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">Asthma</td><td valign="middle" align="center" rowspan="1" colspan="1">13.1</td><td valign="middle" align="center" rowspan="1" colspan="1">12.1-14.0</td><td valign="middle" align="center" rowspan="1" colspan="1">17.2</td><td valign="middle" align="center" rowspan="1" colspan="1">16.0-18.5</td><td valign="middle" align="center" rowspan="1" colspan="1">8.2</td><td valign="middle" align="center" rowspan="1" colspan="1">8.1-8.3</td><td valign="middle" align="center" rowspan="1" colspan="1">11.5</td><td valign="middle" align="center" rowspan="1" colspan="1">11.4-11.7</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">Cardiac Arrhythmia</td><td valign="middle" align="center" rowspan="1" colspan="1">14.5</td><td valign="middle" align="center" rowspan="1" colspan="1">13.6-15.5</td><td valign="middle" align="center" rowspan="1" colspan="1">12.0</td><td valign="middle" align="center" rowspan="1" colspan="1">11.1-13.1</td><td valign="middle" align="center" rowspan="1" colspan="1">11.7</td><td valign="middle" align="center" rowspan="1" colspan="1">11.6-11.9</td><td valign="middle" align="center" rowspan="1" colspan="1">8.0</td><td valign="middle" align="center" rowspan="1" colspan="1">7.9-8.1</td></tr><tr><td valign="bottom" align="left" rowspan="1" colspan="1">Chronic Kidney Disease</td><td valign="middle" align="center" rowspan="1" colspan="1">45.9</td><td valign="middle" align="center" rowspan="1" colspan="1">44.3-47.6</td><td valign="middle" align="center" rowspan="1" colspan="1">38.3</td><td valign="middle" align="center" rowspan="1" colspan="1">36.4-40.3</td><td valign="middle" align="center" rowspan="1" colspan="1">32.5</td><td valign="middle" align="center" rowspan="1" colspan="1">32.3-32.8</td><td valign="middle" align="center" rowspan="1" colspan="1">24.4</td><td valign="middle" align="center" rowspan="1" colspan="1">24.3-24.6</td></tr><tr><td valign="bottom" align="left" rowspan="1" colspan="1">Congestive Heart Failure</td><td valign="middle" align="center" rowspan="1" colspan="1">33.7</td><td valign="middle" align="center" rowspan="1" colspan="1">32.2-35.3</td><td valign="middle" align="center" rowspan="1" colspan="1">32.7</td><td valign="middle" align="center" rowspan="1" colspan="1">30.9-34.6</td><td valign="middle" align="center" rowspan="1" colspan="1">24.6</td><td valign="middle" align="center" rowspan="1" colspan="1">24.4-24.8</td><td valign="middle" align="center" rowspan="1" colspan="1">20.3</td><td valign="middle" align="center" rowspan="1" colspan="1">20.1-20.5</td></tr><tr><td valign="bottom" align="left" rowspan="1" colspan="1">COPD</td><td valign="middle" align="center" rowspan="1" colspan="1">28.7</td><td valign="middle" align="center" rowspan="1" colspan="1">27.3-30.1</td><td valign="middle" align="center" rowspan="1" colspan="1">27.5</td><td valign="middle" align="center" rowspan="1" colspan="1">25.9-29.2</td><td valign="middle" align="center" rowspan="1" colspan="1">20.6</td><td valign="middle" align="center" rowspan="1" colspan="1">20.4-20.7</td><td valign="middle" align="center" rowspan="1" colspan="1">17.2</td><td valign="middle" align="center" rowspan="1" colspan="1">17.0-17.3</td></tr><tr><td valign="bottom" align="left" rowspan="1" colspan="1">Coronary Artery Disease</td><td valign="middle" align="center" rowspan="1" colspan="1">54.6</td><td valign="middle" align="center" rowspan="1" colspan="1">52.9-56.4</td><td valign="middle" align="center" rowspan="1" colspan="1">45.9</td><td valign="middle" align="center" rowspan="1" colspan="1">43.8-48.0</td><td valign="middle" align="center" rowspan="1" colspan="1">46.4</td><td valign="middle" align="center" rowspan="1" colspan="1">46.1-46.6</td><td valign="middle" align="center" rowspan="1" colspan="1">32.9</td><td valign="middle" align="center" rowspan="1" colspan="1">32.7-33.1</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">Hyperlipemia</td><td valign="middle" align="center" rowspan="1" colspan="1">77.1</td><td valign="middle" align="center" rowspan="1" colspan="1">75.4-78.6</td><td valign="middle" align="center" rowspan="1" colspan="1">71.6</td><td valign="middle" align="center" rowspan="1" colspan="1">69.3-73.8</td><td valign="middle" align="center" rowspan="1" colspan="1">67.7</td><td valign="middle" align="center" rowspan="1" colspan="1">67.3-67.8</td><td valign="middle" align="center" rowspan="1" colspan="1">65.4</td><td valign="middle" align="center" rowspan="1" colspan="1">65.2-65.6</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">Hypertension</td><td valign="middle" align="center" rowspan="1" colspan="1">85.2</td><td valign="middle" align="center" rowspan="1" colspan="1">84.0-86.3</td><td valign="middle" align="center" rowspan="1" colspan="1">82.6</td><td valign="middle" align="center" rowspan="1" colspan="1">80.8-84.3</td><td valign="middle" align="center" rowspan="1" colspan="1">78.1</td><td valign="middle" align="center" rowspan="1" colspan="1">77.9-78.2</td><td valign="middle" align="center" rowspan="1" colspan="1">75.7</td><td valign="middle" align="center" rowspan="1" colspan="1">75.5-75.9</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">Stroke</td><td valign="middle" align="center" rowspan="1" colspan="1">15.1</td><td valign="middle" align="center" rowspan="1" colspan="1">14.1-16.2</td><td valign="middle" align="center" rowspan="1" colspan="1">15.8</td><td valign="middle" align="center" rowspan="1" colspan="1">14.6-17.1</td><td valign="middle" align="center" rowspan="1" colspan="1">11.8</td><td valign="middle" align="center" rowspan="1" colspan="1">11.6-11.9</td><td valign="middle" align="center" rowspan="1" colspan="1">10.7</td><td valign="middle" align="center" rowspan="1" colspan="1">10.6-10.8</td></tr><tr><th valign="middle" colspan="9" align="left" rowspan="1">INFECTIOUS DISEASES</th></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">Hepatitis</td><td valign="middle" align="center" rowspan="1" colspan="1">4.3</td><td valign="middle" align="center" rowspan="1" colspan="1">3.7-5.1</td><td valign="middle" align="center" rowspan="1" colspan="1">3.0</td><td valign="middle" align="center" rowspan="1" colspan="1">2.4-3.7</td><td valign="middle" align="center" rowspan="1" colspan="1">1.8</td><td valign="middle" align="center" rowspan="1" colspan="1">1.7-1.9</td><td valign="middle" align="center" rowspan="1" colspan="1">1.2</td><td valign="middle" align="center" rowspan="1" colspan="1">1.2-1.3</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">HIV/AIDS</td><td valign="middle" align="center" rowspan="1" colspan="1">0.9</td><td valign="middle" align="center" rowspan="1" colspan="1">0.6-1.2</td><td valign="middle" align="center" rowspan="1" colspan="1">0.1</td><td valign="middle" align="center" rowspan="1" colspan="1">0.0-0.3</td><td valign="middle" align="center" rowspan="1" colspan="1">0.2</td><td valign="middle" align="center" rowspan="1" colspan="1">0.2-0.2</td><td valign="middle" align="center" rowspan="1" colspan="1">0.1</td><td valign="middle" align="center" rowspan="1" colspan="1">0.1-0.1</td></tr><tr><th valign="middle" colspan="9" align="left" rowspan="1">OTHER HEALTH CONDITIONS</th></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">Arthritis</td><td valign="middle" align="center" rowspan="1" colspan="1">47.3</td><td valign="middle" align="center" rowspan="1" colspan="1">45.5-49.1</td><td valign="middle" align="center" rowspan="1" colspan="1">64.0</td><td valign="middle" align="center" rowspan="1" colspan="1">61.7-66.3</td><td valign="middle" align="center" rowspan="1" colspan="1">36.0</td><td valign="middle" align="center" rowspan="1" colspan="1">35.8-36.2</td><td valign="middle" align="center" rowspan="1" colspan="1">46.8</td><td valign="middle" align="center" rowspan="1" colspan="1">46.5-47.0</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">Diabetes</td><td valign="middle" align="center" rowspan="1" colspan="1">46.7</td><td valign="middle" align="center" rowspan="1" colspan="1">45.1-48.3</td><td valign="middle" align="center" rowspan="1" colspan="1">40.7</td><td valign="middle" align="center" rowspan="1" colspan="1">38.8-42.6</td><td valign="middle" align="center" rowspan="1" colspan="1">40.3</td><td valign="middle" align="center" rowspan="1" colspan="1">40.1-40.5</td><td valign="middle" align="center" rowspan="1" colspan="1">34.3</td><td valign="middle" align="center" rowspan="1" colspan="1">34.1-34.5</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">Osteoporosis</td><td valign="middle" align="center" rowspan="1" colspan="1">6.2</td><td valign="middle" align="center" rowspan="1" colspan="1">5.7-6.9</td><td valign="middle" align="center" rowspan="1" colspan="1">28.8</td><td valign="middle" align="center" rowspan="1" colspan="1">27.2-30.6</td><td valign="middle" align="center" rowspan="1" colspan="1">3.7</td><td valign="middle" align="center" rowspan="1" colspan="1">3.6-3.7</td><td valign="middle" align="center" rowspan="1" colspan="1">23.2</td><td valign="middle" align="center" rowspan="1" colspan="1">22.9-23.4</td></tr><tr><th valign="middle" colspan="9" align="left" rowspan="1">MENTAL HEALTH CONDITIONS</th></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">Dementia</td><td valign="middle" align="center" rowspan="1" colspan="1">20.2</td><td valign="middle" align="center" rowspan="1" colspan="1">19.0-21.5</td><td valign="middle" align="center" rowspan="1" colspan="1">21.3</td><td valign="middle" align="center" rowspan="1" colspan="1">19.8-22.9</td><td valign="middle" align="center" rowspan="1" colspan="1">12.3</td><td valign="middle" align="center" rowspan="1" colspan="1">12.2-12.5</td><td valign="middle" align="center" rowspan="1" colspan="1">13.6</td><td valign="middle" align="center" rowspan="1" colspan="1">13.4-13.8</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">Depression</td><td valign="middle" align="center" rowspan="1" colspan="1">35.9</td><td valign="middle" align="center" rowspan="1" colspan="1">34.4-37.4</td><td valign="middle" align="center" rowspan="1" colspan="1">42.4</td><td valign="middle" align="center" rowspan="1" colspan="1">40.5-44.3</td><td valign="middle" align="center" rowspan="1" colspan="1">16.3</td><td valign="middle" align="center" rowspan="1" colspan="1">16.1-16.4</td><td valign="middle" align="center" rowspan="1" colspan="1">25.5</td><td valign="middle" align="center" rowspan="1" colspan="1">25.3-25.7</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">Schizophrenia</td><td valign="middle" align="center" rowspan="1" colspan="1">7.0</td><td valign="middle" align="center" rowspan="1" colspan="1">6.3-7.7</td><td valign="middle" align="center" rowspan="1" colspan="1">6.2</td><td valign="middle" align="center" rowspan="1" colspan="1">5.5-7.0</td><td valign="middle" align="center" rowspan="1" colspan="1">3.2</td><td valign="middle" align="center" rowspan="1" colspan="1">3.1-3.3</td><td valign="middle" align="center" rowspan="1" colspan="1">3.6</td><td valign="middle" align="center" rowspan="1" colspan="1">3.5-3.6</td></tr><tr><th valign="middle" colspan="9" align="left" rowspan="1">SUBSTANCE USE DISORDERS</th></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">Alcohol</td><td valign="middle" align="center" rowspan="1" colspan="1">6.3</td><td valign="middle" align="center" rowspan="1" colspan="1">5.7-7.0</td><td valign="middle" align="center" rowspan="1" colspan="1">2.9</td><td valign="middle" align="center" rowspan="1" colspan="1">2.4-3.5</td><td valign="middle" align="center" rowspan="1" colspan="1">4.1</td><td valign="middle" align="center" rowspan="1" colspan="1">4.0-4.2</td><td valign="middle" align="center" rowspan="1" colspan="1">1.4</td><td valign="middle" align="center" rowspan="1" colspan="1">1.4-1.4</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">Drug</td><td valign="middle" align="center" rowspan="1" colspan="1">3.7</td><td valign="middle" align="center" rowspan="1" colspan="1">3.2-4.2</td><td valign="middle" align="center" rowspan="1" colspan="1">4.1</td><td valign="middle" align="center" rowspan="1" colspan="1">3.5-4.7</td><td valign="middle" align="center" rowspan="1" colspan="1">1.7</td><td valign="middle" align="center" rowspan="1" colspan="1">1.7-1.8</td><td valign="middle" align="center" rowspan="1" colspan="1">1.7</td><td valign="middle" align="center" rowspan="1" colspan="1">1.6-1.7</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">Tobacco</td><td valign="middle" align="center" rowspan="1" colspan="1">11.3</td><td valign="middle" align="center" rowspan="1" colspan="1">10.5-12.1</td><td valign="middle" align="center" rowspan="1" colspan="1">9.1</td><td valign="middle" align="center" rowspan="1" colspan="1">8.2-10.0</td><td valign="middle" align="center" rowspan="1" colspan="1">8.7</td><td valign="middle" align="center" rowspan="1" colspan="1">8.5-8.8</td><td valign="middle" align="center" rowspan="1" colspan="1">5.8</td><td valign="middle" align="center" rowspan="1" colspan="1">5.7-5.9</td></tr></tbody></table><table-wrap-foot><fn><p>TFN, Trans Feminine and Nonbinary; TMN, Trans Masculine and Nonbinary; 95% CI, Confidence Interval. COPD: Chronic obstructive pulmonary disease. This model adjusted for age, race/ethnicity, census region, and months of enrollment. Unclassified individuals were included in the model but not shown for clarity of presentation. For the within- and between-group gender comparisons, 94% were significant at p&lt;0.05 and p&lt;0.01; 91% were significant at p&lt;0.001. There were no significant differences (p&gt;0.05) between TFN and TMN people for: colorectal cancer, lung cancer, congestive heart failure, COPD, dementia, schizophrenia, and drug use disorder. There were no significant differences (p&gt;0.05) between TFN and cisgender females for arthritis. There were no significant differences (p&gt;0.05) between TFN and cisgender males for lung cancer. There were no significant differences (p&gt;0.05) between TMN and cisgender males for: colorectal cancer, lung cancer, cardiac arrhythmia, coronary artery disease, diabetes, HIV/AIDS, and tobacco use disorder. See <xref rid="ST2" ref-type="supplementary-material">
<bold>Supplemental Table&#160;2</bold>
</xref> for the estimates and p-values for all comparisons.</p></fn></table-wrap-foot></table-wrap><fig position="float" id="f1" orientation="portrait"><label>Figure&#160;1</label><caption><p>Comparison of the adjusted predicted probabilities of health condition diagnosed stratified by inferred gender among age-entitled transgender and cisgender Medicare beneficiaries, 2008-2017. TFN, Trans Feminine and Nonbinary; TMN, Trans Masculine and Nonbinary. COPD, Chronic obstructive pulmonary disease. The symbols represent the adjusted predicted probabilities when age, enrollment length, race/ethnicity, and census region are set to their means. The 95% confidence intervals are shown in <xref rid="T2" ref-type="table">
<bold>Table&#160;2</bold>
</xref>. Within each diagnostic category, the conditions are represented from high to low based on the probability of each diagnosis for TFN individuals.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="fendo-14-1102348-g001.jpg"/></fig><p>When exploring within-group differences in the transgender population, TFN Medicare beneficiaries had a significantly and notably elevated probability of being diagnosed with HIV/AIDS and alcohol use disorder relative to TMN beneficiaries, whereas TMN beneficiaries had a significantly and notably elevated probability of being diagnosed with breast cancer, arthritis, and osteoporosis relative to TFN beneficiaries (all p&#8217;s&lt;0.001). With the exception of breast cancer, asthma, arthritis, osteoporosis, and each mental health condition, which were significantly elevated among cisgender females, cisgender males had a higher probability of being diagnosed with all other conditions (p&lt;0.01).</p><p>When between-group differences were assessed by those presumed to be assigned a male sex at birth, TFN beneficiaries had a significantly and notably elevated probability of being diagnosed with HIV/AIDS, hepatitis, depression, dementia, schizophrenia, and substance use disorder compared to cisgender male beneficiaries (all p&#8217;s&lt;0.001). When exploring between-group differences by those presumed to be assigned a female sex at birth, the widest disparities were observed between TMN and cisgender female beneficiaries for all heart, lung, and kidney diseases, arthritis, hepatitis, depression, dementia, schizophrenia, and substance use disorder diagnoses, with TMN beneficiaries having a significantly elevated probability of all diagnoses (all p&#8217;s&lt;0.001) except HIV/AIDS, which was comparable (p=0.64).</p><p>When assessing between-group disparities between TFN people and cisgender females, TFN people had a significantly higher probability of having all diagnoses (all p&#8217;s&lt;0.001) except arthritis (p&lt;0.55), with the probability of the following diagnoses being particularly elevated: HIV/AIDS, hepatitis, and all substance use disorders. Conversely, TMN people had a significantly higher probability of being diagnosed with breast cancer, arthritis, osteoporosis, depression, and drug use disorder relative to cisgender males (all p&#8217;s&lt;0.001). In contrast, cisgender males had a significantly higher probability of alcohol use disorder relative to TMN people (p&lt;0.001).</p></sec></sec><sec sec-type="discussion" id="s4"><title>Discussion</title><p>This study advances the fields of endocrinology and population health research through the application of an algorithm that identifies transgender people in Medicare data and stratifies by inferred gender to explore within- and between-group disparities in health diagnoses among aging transgender and cisgender beneficiaries. We found that overall, aging TFN or TMN Medicare beneficiaries had a significantly higher probability of every health diagnosis studied relative to cisgender male or female beneficiaries, with TFN individuals experiencing some of the highest diagnosis burdens relative to other groups. Future application of these methods will enable the study of rare and hormone and anatomy-related conditions among hard-to-reach aging transgender populations and their cisgender counterparts and can inform interventions to address documented health diagnosis disparities (<xref rid="B39" ref-type="bibr">39</xref>).</p><p>In understanding the health diagnosis disparities observed here, it is essential to underscore the role of stigma and its stress-related sequelae that transgender individuals differentially experience throughout their lives relative to cisgender individuals (<xref rid="B7" ref-type="bibr">7</xref>). Indeed, at the structural level, harmful state, federal, and organizational policies may intentionally or unintentionally restrict access to the essential resources (e.g., healthcare, education, employment, housing, public bathrooms, and other accommodations) that transgender people need to maintain their health (<xref rid="B7" ref-type="bibr">7</xref>). Additionally, exposure to interpersonal discrimination, violence, and other sources of enacted stigma at the hands of healthcare providers, family members, employers, educators, sexual partners, and others further restricts access to essential resources and contributes to poor health directly and indirectly through chronic stress (<xref rid="B7" ref-type="bibr">7</xref>). As a person ages, chronic activation of the body&#8217;s stress response system can compromise health over time <italic toggle="yes">via</italic> a process called allostatic load (<xref rid="B40" ref-type="bibr">40</xref>&#8211;<xref rid="B42" ref-type="bibr">42</xref>). Chronic stress is associated with adverse health outcomes, such as cancer, hypertension, diabetes, mood and substance use disorders, and even death (<xref rid="B43" ref-type="bibr">43</xref>, <xref rid="B44" ref-type="bibr">44</xref>), and is therefore theorized to be a primary driver of the health diagnosis disparities observed among aging transgender individuals relative to cisgender individuals in this study (<xref rid="B7" ref-type="bibr">7</xref>).</p><p>Few large-scale studies have explored disparities within transgender populations, and relative to cisgender males and females for health conditions such as breast cancer that are known to differ by assigned birth sex. In the United States, breast cancer is approximately 70-100 times less common among cisgender males than females (<xref rid="B45" ref-type="bibr">45</xref>). Building on prior cancer research with transgender samples (<xref rid="B46" ref-type="bibr">46</xref>&#8211;<xref rid="B50" ref-type="bibr">50</xref>), we found that both TMN people and cisgender females had a significantly elevated probability of a breast cancer diagnosis relative to TFN people and cisgender males. Additionally, although the probability of a breast cancer diagnosis in TFN people was significantly lower than that of cisgender females, it was significantly higher relative to that of cisgender males &#8211; a finding that aligns with data from a younger Dutch cohort study comparing the incidence of breast cancer in TFN people on estrogen to cisgender females and males (<xref rid="B46" ref-type="bibr">46</xref>). Lifetime stress, a risk factor for cancer (<xref rid="B51" ref-type="bibr">51</xref>, <xref rid="B52" ref-type="bibr">52</xref>), together with higher rates of screening among transgender people with breast tissue (<xref rid="B53" ref-type="bibr">53</xref>), may have contributed to the elevated probability of being diagnosed with breast cancer among TFN and TMN people relative to their cisgender counterparts. Higher levels of endogenous estradiol in the blood are also associated with a higher risk of breast cancer (<xref rid="B54" ref-type="bibr">54</xref>), whereas endogenous androgens are known to inhibit the progression of certain types of breast cancer (<xref rid="B46" ref-type="bibr">46</xref>, <xref rid="B55" ref-type="bibr">55</xref>). Decreased testosterone due to the use of antiandrogenic treatment and orchiectomy and denser breast tissue due to the use of exogenous hormones (<xref rid="B56" ref-type="bibr">56</xref>) could increase the risk for certain types of breast cancer in TFN people relative to cisgender males (<xref rid="B46" ref-type="bibr">46</xref>, <xref rid="B55" ref-type="bibr">55</xref>). Still, the risk of taking exogenous estrogen for gender affirmation is no greater for TFN people than it is for cisgender females taking such therapies for other indications (<xref rid="B57" ref-type="bibr">57</xref>&#8211;<xref rid="B59" ref-type="bibr">59</xref>). Moreover, our study found a significantly lower probability of being diagnosed with breast cancer in TFN people as compared to cisgender females, which may be due to TFN people having less breast tissue and lower lifetime exposure to estrogen than cisgender females.</p><p>Notable differences in the probability of osteoporosis and arthritis were also observed among TFN and TMN individuals relative to their cisgender comparators. Specifically, TMN individuals had the highest probability of being diagnosed with osteoporosis and arthritis than all other groups. Further, although the probability of an osteoporosis diagnosis was substantially and significantly lower among TFN people than cisgender females, TFN people had a significantly higher probability of having an osteoporosis diagnosis relative to cisgender males. Our findings align with research showing that osteoporosis and most types of arthritis are more prevalent in older people assigned a female sex at birth than those assigned a male sex at birth (<xref rid="B60" ref-type="bibr">60</xref>&#8211;<xref rid="B62" ref-type="bibr">62</xref>). Obesity, heart disease, and smoking can also increase the risk for rheumatoid arthritis (<xref rid="B60" ref-type="bibr">60</xref>, <xref rid="B63" ref-type="bibr">63</xref>), and our study and prior research suggest that TMN people may be at elevated risk of being diagnosed with these conditions (<xref rid="B3" ref-type="bibr">3</xref>, <xref rid="B64" ref-type="bibr">64</xref>&#8211;<xref rid="B66" ref-type="bibr">66</xref>). Relatedly, known risk factors for osteoporosis in the general population include high alcohol consumption, tobacco use, anorexia nervosa, rheumatoid arthritis, chronic kidney disease, and HIV infection (<xref rid="B59" ref-type="bibr">59</xref>, <xref rid="B62" ref-type="bibr">62</xref>, <xref rid="B67" ref-type="bibr">67</xref>&#8211;<xref rid="B69" ref-type="bibr">69</xref>), all of which (except anorexia, which was not studied) were more commonly diagnosed among TFN or TMN people in our sample relative to cisgender males and females. Low physical activity has also been linked to osteoporosis risk in cisgender people (<xref rid="B62" ref-type="bibr">62</xref>) and transgender people, even before initiating hormones (<xref rid="B59" ref-type="bibr">59</xref>). Research finds that some TFN and TMN individuals have lower levels of physical activity than their cisgender comparators due to various social and physical barriers to exercising, including inadequate changing facilities, revealing and heavily gendered sports clothing, body dissatisfaction, and fears of acceptance (<xref rid="B70" ref-type="bibr">70</xref>&#8211;<xref rid="B72" ref-type="bibr">72</xref>). Additionally, stress is a major risk factor for osteoporosis (<xref rid="B62" ref-type="bibr">62</xref>), and other chronic conditions (e.g., tobacco smoking) that increase osteoporosis and arthritis risk (<xref rid="B61" ref-type="bibr">61</xref>, <xref rid="B62" ref-type="bibr">62</xref>, <xref rid="B73" ref-type="bibr">73</xref>); and as previously noted, transgender individuals experience greater stigma-related stress throughout their lives relative to cisgender people (<xref rid="B7" ref-type="bibr">7</xref>).</p><p>Wear and tear on one&#8217;s joints and changes in hormone levels in older age are associated with a greater risk of arthritis and osteoporosis, respectively (<xref rid="B62" ref-type="bibr">62</xref>, <xref rid="B74" ref-type="bibr">74</xref>, <xref rid="B75" ref-type="bibr">75</xref>). Although there is no evidence to suggest a causal link between exogenous hormone use and arthritis risk in transgender people, in considering osteoporosis risk, the World Professional Association of Transgender Health notes that the use of gender-affirming medical and surgical interventions, such as hormone therapy, androgen blockade, and gonadectomy, have the potential to influence bone health in different ways (<xref rid="B59" ref-type="bibr">59</xref>). While testosterone therapy has been associated with no change or even improvements in bone density among TMN people (<xref rid="B59" ref-type="bibr">59</xref>, <xref rid="B67" ref-type="bibr">67</xref>, <xref rid="B76" ref-type="bibr">76</xref>), the higher probability of being diagnosed with osteoporosis among TMN people in this sample may be due to natural reductions in estrogen among those who experienced menopause (<xref rid="B62" ref-type="bibr">62</xref>, <xref rid="B75" ref-type="bibr">75</xref>). Further, although TFN people have been shown to have improved bone density after initiating estrogen (<xref rid="B59" ref-type="bibr">59</xref>, <xref rid="B67" ref-type="bibr">67</xref>, <xref rid="B77" ref-type="bibr">77</xref>, <xref rid="B78" ref-type="bibr">78</xref>), risk factors for osteoporosis include the absence of or underutilization of estrogen after gonadectomy or the use of androgen blockers without or with insufficient estrogen (<xref rid="B59" ref-type="bibr">59</xref>, <xref rid="B67" ref-type="bibr">67</xref>, <xref rid="B79" ref-type="bibr">79</xref>). Further, although Gonadotropin-Releasing Hormone Agonists (GnRHa) are very effective in reducing testosterone levels to help TFN individuals achieve their gender-affirmation goals, the use of GnRHA can result in osteoporosis if concurrent doses of estrogen are insufficient (<xref rid="B59" ref-type="bibr">59</xref>, <xref rid="B67" ref-type="bibr">67</xref>, <xref rid="B80" ref-type="bibr">80</xref>). In light of prior research, our findings underscore the necessity for clinicians to understand the various physiological, developmental, behavioral, and environmental risk and protective factors for osteoporosis and other health conditions in order to support aging transgender and cisgender individuals in optimizing their health and well-being.</p><p>When exploring mental health, in alignment with prior research (<xref rid="B5" ref-type="bibr">5</xref>, <xref rid="B12" ref-type="bibr">12</xref>, <xref rid="B13" ref-type="bibr">13</xref>, <xref rid="B30" ref-type="bibr">30</xref>, <xref rid="B59" ref-type="bibr">59</xref>, <xref rid="B81" ref-type="bibr">81</xref>), this study found a significantly higher probability of all mental health diagnoses among both aging TFN and TMN Medicare beneficiaries relative to their cisgender counterparts. Although TFN and TMN people had a similar probability of having a dementia diagnosis, the probability among TFN and TMN people was significantly elevated relative to cisgender males and females. Further, although depression diagnoses were also significantly elevated among TFN and TMN people compared to the cisgender subgroups, both TMN people and cisgender females had a significantly higher probability of depression than TFN people and cisgender males, respectively. Prior research finds that individuals assigned a female sex at birth are twice as likely to be diagnosed with depression than people assigned a male sex at birth (<xref rid="B82" ref-type="bibr">82</xref>, <xref rid="B83" ref-type="bibr">83</xref>), which is consistent with our findings. Burgeoning research also finds an elevated probability of Alzheimer&#8217;s disease and related dementias (<xref rid="B84" ref-type="bibr">84</xref>) and schizophrenia (<xref rid="B85" ref-type="bibr">85</xref>) diagnoses among transgender people relative to cisgender individuals. Although the mechanisms underlying these disparities are not well understood, misdiagnoses by untrained or biased providers may contribute to more diagnoses for transgender people, particularly in the case of schizophrenia (<xref rid="B59" ref-type="bibr">59</xref>, <xref rid="B60" ref-type="bibr">60</xref>). Additionally, transgender people have historically been required to undergo psychotherapy to be approved for medical gender affirmation treatment (<xref rid="B86" ref-type="bibr">86</xref>&#8211;<xref rid="B88" ref-type="bibr">88</xref>); thus, the higher probability of mental health diagnoses observed here may be due to increased contact with mental health specialists rather than a reflection of the true probability of these conditions in aging transgender populations (<xref rid="B85" ref-type="bibr">85</xref>). Nonetheless, extensive research has documented disparities in poor mental health among transgender vs. cisgender individuals (<xref rid="B2" ref-type="bibr">2</xref>, <xref rid="B59" ref-type="bibr">59</xref>, <xref rid="B89" ref-type="bibr">89</xref>). Given that the onset of depression, dementia, cognitive decline, and schizophrenia have all been linked to stress in both transgender and cisgender samples (<xref rid="B7" ref-type="bibr">7</xref>, <xref rid="B90" ref-type="bibr">90</xref>&#8211;<xref rid="B96" ref-type="bibr">96</xref>), it is quite probable that the elevated mental health burden observed among aging transgender people in this sample is due to the high levels of stigma-related stress that transgender people experience throughout the life course including in the context of receiving medical care (<xref rid="B7" ref-type="bibr">7</xref>, <xref rid="B26" ref-type="bibr">26</xref>, <xref rid="B97" ref-type="bibr">97</xref>).</p><p>Some of the most striking within- and between- gender group diagnostic disparities were observed with regard to infectious diseases. The probability of HIV/AIDS among TFN people was approximately 9-fold that of TMN people and cisgender females and 4.5-fold that of cisgender males. The high probability of HIV/AIDS among TFN people is well documented in the literature (<xref rid="B4" ref-type="bibr">4</xref>, <xref rid="B12" ref-type="bibr">12</xref>, <xref rid="B13" ref-type="bibr">13</xref>, <xref rid="B98" ref-type="bibr">98</xref>) and has been attributed to multilevel factors. For example, TFN people may acquire HIV at higher rates due to networks-level factors such as the high prevalence of HIV within TFN people&#8217;s limited pool of potential sexual partners or anatomical considerations that predispose TFN people with a penis to engage in sexual acts that carry greater HIV risk (i.e., receptive anal sex) (<xref rid="B99" ref-type="bibr">99</xref>, <xref rid="B100" ref-type="bibr">100</xref>). A confluence of stigma-related, structural, and interpersonal factors also restrict access to essential human needs (i.e., employment, shelter, food, love, gender affirmation) for TFN people (<xref rid="B7" ref-type="bibr">7</xref>) and can lead to engagement in HIV risk behavior such as transactional sex for financial survival (<xref rid="B99" ref-type="bibr">99</xref>, <xref rid="B100" ref-type="bibr">100</xref>), receptive anal sex (i.e., &#8220;bottoming&#8221;) as a means to be affirmed in one&#8217;s gender when access to other sources of affirmation are limited (<xref rid="B100" ref-type="bibr">100</xref>&#8211;<xref rid="B102" ref-type="bibr">102</xref>), and condomless sex to please one&#8217;s sexual partner in the context of relationship stigma and partner scarcity (<xref rid="B100" ref-type="bibr">100</xref>, <xref rid="B103" ref-type="bibr">103</xref>, <xref rid="B104" ref-type="bibr">104</xref>). Similarly, the probability of hepatitis was significantly higher among TFN people than all other groups, and the probability of a hepatitis diagnosis among TMN people was roughly twice that of cisgender males and females. In addition to the aforementioned sexual pathways, the significantly higher probability of a hepatitis diagnosis among transgender people relative to cisgender individuals may also be driven by the sharing of syringes for injecting drugs, hormones, and silicone - behaviors that may be more prevalent among transgender people due to stigma-related barriers to healthcare (<xref rid="B7" ref-type="bibr">7</xref>, <xref rid="B99" ref-type="bibr">99</xref>&#8211;<xref rid="B101" ref-type="bibr">101</xref>, <xref rid="B105" ref-type="bibr">105</xref>&#8211;<xref rid="B107" ref-type="bibr">107</xref>).</p><p>Consistent with prior research with Medicare- and commercially-insured individuals (<xref rid="B3" ref-type="bibr">3</xref>, <xref rid="B4" ref-type="bibr">4</xref>, <xref rid="B12" ref-type="bibr">12</xref>, <xref rid="B13" ref-type="bibr">13</xref>, <xref rid="B30" ref-type="bibr">30</xref>), aging transgender Medicare beneficiaries in this sample had a significantly higher probability of most substance use disorder diagnoses than their cisgender comparators. Research has consistently found elevated levels of substance use and diagnosed substance use disorders among transgender samples relative to cisgender samples (<xref rid="B3" ref-type="bibr">3</xref>, <xref rid="B5" ref-type="bibr">5</xref>, <xref rid="B12" ref-type="bibr">12</xref>, <xref rid="B13" ref-type="bibr">13</xref>, <xref rid="B30" ref-type="bibr">30</xref>, <xref rid="B108" ref-type="bibr">108</xref>), due in part to the need to cope with the psychological toll of discrimination, violence, and other forms of stigma (<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B7" ref-type="bibr">7</xref>, <xref rid="B34" ref-type="bibr">34</xref>, <xref rid="B109" ref-type="bibr">109</xref>). In prior studies of younger, commercially-insured transgender individuals (<xref rid="B3" ref-type="bibr">3</xref>, <xref rid="B4" ref-type="bibr">4</xref>, <xref rid="B12" ref-type="bibr">12</xref>, <xref rid="B13" ref-type="bibr">13</xref>), drug, alcohol, and tobacco use disorder diagnoses were particularly elevated among TFN people than TMN people. In contrast, the probability of having a drug use disorder diagnosis was fairly comparable between TFN and TMN people in the current study, though the probability of alcohol and tobacco use disorder diagnoses was significantly elevated among TFN people relative to TMN people in the sample. A similar trend was observed for cisgender individuals, such that cisgender males had a significantly higher probability of alcohol and tobacco use disorder diagnoses than cisgender females. The substance use disorder findings suggest that although stigma likely drives the higher prevalence of substance use disorders observed among transgender people (<xref rid="B7" ref-type="bibr">7</xref>), individuals assigned a male sex at birth may be more susceptible to some substance use disorders than those assigned a female sex at birth (<xref rid="B110" ref-type="bibr">110</xref>, <xref rid="B111" ref-type="bibr">111</xref>). It is also possible that developmental factors may lead individuals assigned a male sex at birth to cope with stress using certain substances more frequently than those assigned a female sex at birth (<xref rid="B110" ref-type="bibr">110</xref>, <xref rid="B111" ref-type="bibr">111</xref>). Although the receipt of a diagnosis is an important step in linkage to treatment, research finds that transgender people face difficulty finding affirming substance use treatment services (<xref rid="B112" ref-type="bibr">112</xref>&#8211;<xref rid="B114" ref-type="bibr">114</xref>). Thus, efforts are needed to effectively prevent and treat substance use disorders among transgender people by reducing societal stigma (<xref rid="B7" ref-type="bibr">7</xref>), helping transgender people to cope with stigma through health-promoting means (<xref rid="B115" ref-type="bibr">115</xref>, <xref rid="B116" ref-type="bibr">116</xref>), and improving access to gender-affirming substance use treatment services (<xref rid="B117" ref-type="bibr">117</xref>).</p><sec id="s4_1"><title>Clinical and research implications</title><p>Although TFN or TMN aging adults in our sample had a significantly higher probability of receiving specific health diagnoses relative to one or both cisgender subgroups, current, evidenced-based clinical care guidelines (<xref rid="B59" ref-type="bibr">59</xref>) show that the use of exogenous hormones carries similar risks for various health outcomes in both transgender and cisgender populations (e.g., risk of breast cancer in TFN people taking estrogen is no greater than for cisgender women taking estrogen for other indications) (<xref rid="B57" ref-type="bibr">57</xref>&#8211;<xref rid="B59" ref-type="bibr">59</xref>). Thus, research such as ours, which shows disparities in health diagnoses rather than the true prevalence of disease in transgender and cisgender people, should not be used to create differential access to medically-necessary treatment for transgender people (<xref rid="B59" ref-type="bibr">59</xref>, <xref rid="B87" ref-type="bibr">87</xref>, <xref rid="B88" ref-type="bibr">88</xref>).</p><p>Significant advancements in endocrinology and transgender medicine in recent years have helped to ensure the safe and effective delivery of medically-necessary gender-affirming hormones and surgical treatments to transgender people and have led to improvements in the psychological well-being and quality of life for transgender individuals accessing such care (<xref rid="B59" ref-type="bibr">59</xref>, <xref rid="B118" ref-type="bibr">118</xref>). Given that this study focuses on aging transgender individuals, it is possible that some of the health diagnosis disparities observed here are due to their past utilization of older treatment regimens prior to the advent of quality care guidelines, as well as a confluence of stigma-related social, behavioral, and environmental risk factors that shaped access to and use of quality gender-affirming medical care (<xref rid="B7" ref-type="bibr">7</xref>). Our findings, together with prior research, underscore the need for high-quality, prospective research to identify the multitude of risk factors that may contribute to the health diagnosis disparities observed here. Such research should include ongoing, rigorous examinations of the risk and protective effects of gender-affirming hormone therapy and surgery and evaluations into whether transgender individuals are able to access guideline-concordant care. Such data can help to [1] improve healthcare providers&#8217; ability to provide quality care to transgender patients; [2] ensure that transgender individuals receive the requisite information to provide fully informed consent when accessing medically-necessary and psychologically-beneficial medications and procedures to affirm their gender (<xref rid="B59" ref-type="bibr">59</xref>, <xref rid="B118" ref-type="bibr">118</xref>, <xref rid="B119" ref-type="bibr">119</xref>); and [3] inform clinical and policy interventions aimed at improving the health and well-being of transgender people.</p></sec><sec id="s4_2"><title>Limitations</title><p>The study has limitations. First, since transgender beneficiaries were included in our study based on their observed care, we are unable to validate whether individuals we identified as transgender were truly so or whether individuals we characterized as cisgender based on their absence of qualifying care were actually cisgender. Second, since our administrative data did not capture gender identity, we were forced to infer the gender identity of our sample and combine individuals who likely hold nonbinary and binary gender identities in the same category based on their shared use of certain gender-affirming hormones, procedures, or anatomy-specific care. Nonbinary transgender people have been shown to have differential healthcare utilization and risk of various health outcomes than binary transgender people (<xref rid="B32" ref-type="bibr">32</xref>, <xref rid="B120" ref-type="bibr">120</xref>), and so the necessary combining of these groups in the present study may have obscured key differences in the probability of being diagnosed with one or more health conditions. Third, transgender and cisgender beneficiaries were included in our study based on their observed care, whereas individuals who did not access relevant care through fee-for-service Medicare at any point during the study period were not included; thus, our sample is unlikely to represent all aging transgender and cisgender Medicare beneficiaries. Fourth, our estimated burden of health diagnoses was based on a methodology that relies on healthcare utilization, and the longer individuals were enrolled in Medicare, the more time they had to engage in healthcare and receive a diagnosis. Since transgender individuals, on average, had more months of enrollment in fee-for-service Medicare than cisgender individuals, we adjusted for months of enrollment. However, undiagnosed or underdiagnosed conditions within any of the gender groups would result in an undercount of the true burden of disease. Further, as noted earlier, transgender individuals forced reliance on the healthcare system to receive gender-affirming care may have led to higher healthcare utilization and more opportunities to receive a health diagnosis relative to cisgender people. Fifth, our analyses may be prone to bias due to unmeasured confounding. Specifically, the effect of social risk factors such as education, housing stability, and income could not be assessed using our data. Still, our findings align with and extend other claims-based, survey, and clinical studies and act as a signal for future research and intervention efforts.</p></sec></sec><sec sec-type="conclusion" id="s5"><title>Conclusion</title><p>We adapted prior algorithms (<xref rid="B3" ref-type="bibr">3</xref>, <xref rid="B13" ref-type="bibr">13</xref>, <xref rid="B33" ref-type="bibr">33</xref>) to identify a large sample of aging transgender Medicare beneficiaries and examine within- and between-group differences in health diagnoses among transgender people and their cisgender counterparts. Extending prior research (<xref rid="B3" ref-type="bibr">3</xref>, <xref rid="B5" ref-type="bibr">5</xref>, <xref rid="B12" ref-type="bibr">12</xref>, <xref rid="B13" ref-type="bibr">13</xref>, <xref rid="B30" ref-type="bibr">30</xref>, <xref rid="B31" ref-type="bibr">31</xref>, <xref rid="B33" ref-type="bibr">33</xref>), we observed an elevated burden of health condition diagnoses among TFN or TMN people overall, with the greatest burden observed among TFN people relative to other groups. Our novel methods to identify a transgender sample using Medicare claims data and infer gender may be helpful for future researchers seeking to study the diagnosis of rare conditions, as well as identify transgender subgroups in need of preventive and treatment interventions aimed at reducing morbidity (<xref rid="B26" ref-type="bibr">26</xref>, <xref rid="B29" ref-type="bibr">29</xref>, <xref rid="B30" ref-type="bibr">30</xref>, <xref rid="B32" ref-type="bibr">32</xref>) and mortality (<xref rid="B42" ref-type="bibr">42</xref>, <xref rid="B121" ref-type="bibr">121</xref>) among aging transgender people in the U.S.</p></sec><sec sec-type="data-availability" id="s6"><title>Data availability statement</title><p>The original contributions presented in the study are included in the article/<xref rid="ST1" ref-type="supplementary-material"><bold>Supplementary Material</bold></xref>. Further inquiries can be directed to the corresponding author.</p></sec><sec sec-type="ethics-statement" id="s7"><title>Ethics statement</title><p>This study was approved by the Brown University Institutional Review Board. Written informed consent from the participants was not required to participate in this study in accordance with national legislation and institutional requirements.</p></sec><sec sec-type="author-contributions" id="s8"><title>Author contributions</title><p>JH and TS conceived the project and wrote the grants that funded access to the data and supported the analyst's time. JH, TS, AA, JE, LH, KY, and JD were involved in developing the methods to identify the transgender sample and stratify the sample by inferred gender. All authors were involved in refining the algorithm. JH wrote and edited the manuscript and designed and edited the tables and supplementary figures. HV conducted the analyses and populated the tables. KY and LH reviewed the statistical code. GB contributed to the writing of the introduction and formatting of the paper. KY created <xref rid="f1" ref-type="fig">
<bold>Figure&#160;1</bold>
</xref>. All authors contributed to the article and approved the submitted version.</p></sec></body><back><fn-group><fn id="fn1"><label>1</label><p>Yee, Lind, &amp; Downing (2021) used inferred sex assigned birth sex instead of inferred gender identity when stratifying the transgender sample.</p></fn><fn id="fn2"><label>2</label><p>Reproductive-anatomy-related care was previously referred to as &#8220;sex-specific care&#8221;. Since people assigned the same sex at birth may have different anatomies, we revised the term to be more specific to anatomy.</p></fn><fn id="fn3"><label>3</label><p>It is not possible to determine the true gender identity or assigned birth sex of individuals identified in claims data. Drawing on Jasuja and colleagues&#8217; formative research and consultations with transgender clinicians, researchers, and community advisory board members and extending our prior work, we categorized the transgender sample based on inferred gender as opposed to inferred sex assigned at birth. We considered inferred gender population. There was also the concern that referring to transgender subgroups based on their assigned birth sex would effectively sanction the practice of referring to transgender people by their assigned birth sex as opposed to their self-reported gender identity in clinical and other encounters, which is not affirming or appropriate.</p></fn><fn id="fn4"><label>4</label><p>TFN people represent people who take gender-affirming hormones or who have received gender-affirming procedures to achieve a nonbinary-to-feminine gender expression and/or who have had other types of diagnoses, or reproductive anatomy-specific procedures common to someone assigned a male birth sex (e.g., prostate-related care). TMN people represent people taking gender-affirming hormones or who have received gender-affirming procedures to achieve a nonbinary-to-masculine gender expression and/or who have had other types of diagnoses, or reproductive anatomy-related procedures common to someone assigned a female birth sex (e.g., hysterectomy).</p></fn></fn-group><sec sec-type="COI-statement" id="s10"><title>Conflict of interest</title><p>The authors declare that the research was conducted without any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec><sec sec-type="disclaimer" id="s11"><title>Publisher&#8217;s note</title><p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p></sec><sec sec-type="supplementary-material" id="s12"><title>Supplementary material</title><p>The Supplementary Material for this article can be found online at: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.frontiersin.org/articles/10.3389/fendo.2023.1102348/full#supplementary-material" ext-link-type="uri">https://www.frontiersin.org/articles/10.3389/fendo.2023.1102348/full#supplementary-material</ext-link>
</p><supplementary-material id="ST1" position="float" content-type="local-data" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Table_1.pdf" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material id="ST2" position="float" content-type="local-data" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Table_2.pdf" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material id="SF1" position="float" content-type="local-data" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Image_1.jpeg" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material id="SF2" position="float" content-type="local-data" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Image_2.jpeg" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec><ref-list><title>References</title><ref id="B1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Reisner</surname><given-names>SL</given-names></name><name name-style="western"><surname>White</surname><given-names>JM</given-names></name><name name-style="western"><surname>Bradford</surname><given-names>J</given-names></name><name name-style="western"><surname>Mimiaga</surname><given-names>MJ</given-names></name></person-group>. <article-title>Transgender health disparities: Comparing full cohort and nested matched-pair study designs in a community health center</article-title>. <source>LGBT Health</source> (<year>2014</year>) <volume>1</volume>(<issue>3</issue>):<page-range>177&#8211;84</page-range>. doi: <pub-id pub-id-type="doi">10.1089/lgbt.2014.0009</pub-id><pub-id pub-id-type="pmcid">PMC4219512</pub-id><pub-id pub-id-type="pmid">25379511</pub-id></mixed-citation></ref><ref id="B2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Su</surname><given-names>D</given-names></name><name name-style="western"><surname>Irwin</surname><given-names>JA</given-names></name><name name-style="western"><surname>Fisher</surname><given-names>C</given-names></name><name name-style="western"><surname>Ramos</surname><given-names>A</given-names></name><name name-style="western"><surname>Kelley</surname><given-names>M</given-names></name><name name-style="western"><surname>Mendoza</surname><given-names>DAR</given-names></name><etal/></person-group>. <article-title>Mental health disparities within the LGBT population: A comparison between transgender and nontransgender individuals</article-title>. <source>Transgend Health</source> (<year>2016</year>) <volume>1</volume>(<issue>1</issue>):<fpage>12</fpage>&#8211;<lpage>20</lpage>. doi: <pub-id pub-id-type="doi">10.1089/trgh.2015.0001</pub-id><pub-id pub-id-type="pmid">29159294</pub-id><pub-id pub-id-type="pmcid">PMC5685247</pub-id></mixed-citation></ref><ref id="B3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hughto</surname><given-names>JMW</given-names></name><name name-style="western"><surname>Quinn</surname><given-names>EK</given-names></name><name name-style="western"><surname>Dunbar</surname><given-names>M</given-names></name><name name-style="western"><surname>Rose</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Shireman</surname><given-names>TI</given-names></name><name name-style="western"><surname>Jasjua</surname><given-names>GK</given-names></name></person-group>. <article-title>Prevalence and co-occurrence of alcohol, nicotine, and other substance use disorder diagnoses among US transgender and cisgender adults</article-title>. <source>JAMA Netw Open</source> (<year>2021</year>) <volume>4</volume>(<issue>2</issue>):<elocation-id>e2036512</elocation-id>. doi: <pub-id pub-id-type="doi">10.1001/jamanetworkopen.2020.36512</pub-id><pub-id pub-id-type="pmid">33538824</pub-id><pub-id pub-id-type="pmcid">PMC7862992</pub-id></mixed-citation></ref><ref id="B4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hughes</surname><given-names>L</given-names></name><name name-style="western"><surname>Shireman</surname><given-names>TI</given-names></name><name name-style="western"><surname>Hughto</surname><given-names>J</given-names></name></person-group>. <article-title>Privately insured transgender people are at elevated risk for chronic conditions compared with cisgender counterparts</article-title>. <source>Health Aff</source> (<year>2021</year>) <volume>40</volume>(<issue>9</issue>):<page-range>1440&#8211;8</page-range>. doi: <pub-id pub-id-type="doi">10.1377/hlthaff.2021.00546</pub-id><pub-id pub-id-type="pmcid">PMC8482030</pub-id><pub-id pub-id-type="pmid">34519545</pub-id></mixed-citation></ref><ref id="B5"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brown</surname><given-names>GR</given-names></name><name name-style="western"><surname>Jones</surname><given-names>KT</given-names></name></person-group>. <article-title>Mental health and medical health disparities in 5135 transgender veterans receiving healthcare in the veterans health administration: A case&#8211;control study</article-title>. <source>LGBT Health</source> (<year>2016</year>) <volume>3</volume>(<issue>2</issue>):<page-range>122&#8211;31</page-range>. doi: <pub-id pub-id-type="doi">10.1089/lgbt.2015.0058</pub-id><pub-id pub-id-type="pmid">26674598</pub-id></mixed-citation></ref><ref id="B6"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Day</surname><given-names>JK</given-names></name><name name-style="western"><surname>Fish</surname><given-names>JN</given-names></name><name name-style="western"><surname>Perez-Brumer</surname><given-names>A</given-names></name><name name-style="western"><surname>Hatzenbuehler</surname><given-names>ML</given-names></name><name name-style="western"><surname>Russell</surname><given-names>ST</given-names></name></person-group>. <article-title>Transgender youth substance use disparities: Results from a population-based sample</article-title>. <source>J Adolesc Health</source> (<year>2017</year>) <volume>61</volume>(<issue>6</issue>):<page-range>729&#8211;35</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.jadohealth.2017.06.024</pub-id><pub-id pub-id-type="pmcid">PMC6802742</pub-id><pub-id pub-id-type="pmid">28942238</pub-id></mixed-citation></ref><ref id="B7"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>White Hughto</surname><given-names>JM</given-names></name><name name-style="western"><surname>Reisner</surname><given-names>SL</given-names></name><name name-style="western"><surname>Pachankis</surname><given-names>JE</given-names></name></person-group>. <article-title>Transgender stigma and health: A critical review of stigma determinants, mechanisms, and interventions</article-title>. <source>Soc Sci Med</source> (<year>2015</year>) <volume>147</volume>:<page-range>222&#8211;31</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.socscimed.2015.11.010</pub-id><pub-id pub-id-type="pmcid">PMC4689648</pub-id><pub-id pub-id-type="pmid">26599625</pub-id></mixed-citation></ref><ref id="B8"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hendricks</surname><given-names>ML</given-names></name><name name-style="western"><surname>Testa</surname><given-names>RJ</given-names></name></person-group>. <article-title>A conceptual framework for clinical work with transgender and gender nonconforming clients: An adaptation of the minority stress model</article-title>. <source>Prof Psychology: Res Practice</source> (<year>2012</year>) <volume>43</volume>(<issue>5</issue>):<page-range>460&#8211;7</page-range>. doi: <pub-id pub-id-type="doi">10.1037/a0029597</pub-id></mixed-citation></ref><ref id="B9"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kattari</surname><given-names>SK</given-names></name><name name-style="western"><surname>Hasche</surname><given-names>L</given-names></name></person-group>. <article-title>Differences across age groups in transgender and gender non-conforming people's experiences of health care discrimination, harassment, and victimization</article-title>. <source>J Aging Health</source> (<year>2016</year>) <volume>28</volume>(<issue>2</issue>):<fpage>285</fpage>&#8211;<lpage>306</lpage>. doi: <pub-id pub-id-type="doi">10.1177/0898264315590228</pub-id><pub-id pub-id-type="pmid">26082132</pub-id></mixed-citation></ref><ref id="B10"><label>10</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Grant</surname><given-names>JM</given-names></name><name name-style="western"><surname>Mottet</surname><given-names>LA</given-names></name><name name-style="western"><surname>Tanis</surname><given-names>LA</given-names></name><name name-style="western"><surname>Harrison</surname><given-names>J</given-names></name><name name-style="western"><surname>Herman</surname><given-names>JL</given-names></name><name name-style="western"><surname>Keisling</surname><given-names>M</given-names></name></person-group>. <source>Injustice at every turn: A report of the national transgender discrimination survey</source>. <publisher-loc>Washington, DC</publisher-loc>: <publisher-name>National Center for Transgender Equality and National Gay and Lesbian Task Force</publisher-name>. (<year>2011</year>). Available at: <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.onlabor.org/wp-content/uploads/2016/04/ntds_full.pdf">https://www.onlabor.org/wp-content/uploads/2016/04/ntds_full.pdf</uri></mixed-citation></ref><ref id="B11"><label>11</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>James</surname><given-names>SE</given-names></name><name name-style="western"><surname>Herman</surname><given-names>JL</given-names></name><name name-style="western"><surname>Rankin</surname><given-names>S</given-names></name><name name-style="western"><surname>Keisling</surname><given-names>M</given-names></name><name name-style="western"><surname>Mottet</surname><given-names>L</given-names></name><name name-style="western"><surname>Anafi</surname><given-names>M</given-names></name></person-group>. <source>The report of the 2015 US transgender survey</source>. <publisher-loc>Washington, DC</publisher-loc>: <publisher-name>National Center for Transgender Equality</publisher-name>. (<year>2016</year>). Available at: <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.ustranssurvey.org/report/">http://www.ustranssurvey.org/report/</uri>.</mixed-citation></ref><ref id="B12"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hughto</surname><given-names>J</given-names></name><name name-style="western"><surname>Hughes</surname><given-names>L</given-names></name><name name-style="western"><surname>Yee</surname><given-names>K</given-names></name><name name-style="western"><surname>Downing</surname><given-names>J</given-names></name><name name-style="western"><surname>Ellison</surname><given-names>J</given-names></name><name name-style="western"><surname>Alpert</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Improving data-driven methods to identify and categorize transgender individuals by gender in insurance claims data</article-title>. <source>LGBT Health</source> (<year>2022</year>) <volume>9</volume>(<issue>4</issue>):<page-range>254&#8211;63</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1089/lgbt.2021.0433</pub-id><pub-id pub-id-type="pmcid">PMC9150133</pub-id><pub-id pub-id-type="pmid">35290746</pub-id></mixed-citation></ref><ref id="B13"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jasuja</surname><given-names>GK</given-names></name><name name-style="western"><surname>de Groot</surname><given-names>A</given-names></name><name name-style="western"><surname>Quinn</surname><given-names>EK</given-names></name><name name-style="western"><surname>Ameli</surname><given-names>O</given-names></name><name name-style="western"><surname>Hughto</surname><given-names>JMW</given-names></name><name name-style="western"><surname>Dunbar</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Beyond gender identity disorder diagnoses codes: An examination of additional methods to identify transgender individuals in administrative databases</article-title>. <source>Med Care</source> (<year>2020</year>) <volume>58</volume>(<issue>10</issue>):<page-range>903&#8211;11</page-range>. doi: <pub-id pub-id-type="doi">10.1097/MLR.0000000000001362</pub-id><pub-id pub-id-type="pmcid">PMC8010422</pub-id><pub-id pub-id-type="pmid">32925416</pub-id></mixed-citation></ref><ref id="B14"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Blosnich</surname><given-names>JR</given-names></name><name name-style="western"><surname>Brown</surname><given-names>GR</given-names></name><name name-style="western"><surname>Shipherd</surname><given-names>P</given-names></name><name name-style="western"><surname>Jillian</surname><given-names>C</given-names></name><name name-style="western"><surname>Kauth</surname><given-names>M</given-names></name><name name-style="western"><surname>Piegari</surname><given-names>RI</given-names></name><etal/></person-group>. <article-title>Prevalence of gender identity disorder and suicide risk among transgender veterans utilizing veterans health administration care</article-title>. <source>Am J Public Health</source> (<year>2013</year>) <volume>103</volume>(<issue>10</issue>):<page-range>e27&#8211;32</page-range>. doi: <pub-id pub-id-type="doi">10.2105/AJPH.2013.301507</pub-id><pub-id pub-id-type="pmcid">PMC3780758</pub-id><pub-id pub-id-type="pmid">23947310</pub-id></mixed-citation></ref><ref id="B15"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Conron</surname><given-names>KJ</given-names></name><name name-style="western"><surname>Scott</surname><given-names>G</given-names></name><name name-style="western"><surname>Stowell</surname><given-names>GS</given-names></name><name name-style="western"><surname>Landers</surname><given-names>SJ</given-names></name></person-group>. <article-title>Transgender health in Massachusetts: Results from a household probability sample of adults</article-title>. <source>Am J Public Health</source> (<year>2012</year>) <volume>102</volume>(<issue>1</issue>):<page-range>118&#8211;22</page-range>. doi: <pub-id pub-id-type="doi">10.2105/AJPH.2011.300315</pub-id><pub-id pub-id-type="pmcid">PMC3490554</pub-id><pub-id pub-id-type="pmid">22095354</pub-id></mixed-citation></ref><ref id="B16"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brown</surname><given-names>GR</given-names></name><name name-style="western"><surname>Jones</surname><given-names>KT</given-names></name></person-group>. <article-title>Racial health disparities in a cohort of 5,135 transgender veterans</article-title>. <source>J Racial Ethnic Health Disparities</source> (<year>2014</year>) <volume>1</volume>(<issue>4</issue>):<page-range>257&#8211;66</page-range>. doi: <pub-id pub-id-type="doi">10.1007/s40615-014-0032-4</pub-id></mixed-citation></ref><ref id="B17"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Coulter</surname><given-names>RW</given-names></name><name name-style="western"><surname>Blosnich</surname><given-names>JR</given-names></name><name name-style="western"><surname>Bukowski</surname><given-names>LA</given-names></name><name name-style="western"><surname>Herrick</surname><given-names>A</given-names></name><name name-style="western"><surname>Siconolfi</surname><given-names>DE</given-names></name><name name-style="western"><surname>Stall</surname><given-names>RD</given-names></name></person-group>. <article-title>Differences in alcohol use and alcohol-related problems between transgender- and nontransgender-identified young adults</article-title>. <source>Drug Alcohol Depend</source> (<year>2015</year>) <volume>154</volume>:<page-range>251&#8211;9</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.drugalcdep.2015.07.006</pub-id><pub-id pub-id-type="pmcid">PMC4536098</pub-id><pub-id pub-id-type="pmid">26210734</pub-id></mixed-citation></ref><ref id="B18"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Downing</surname><given-names>JM</given-names></name><name name-style="western"><surname>Przedworski</surname><given-names>JM</given-names></name></person-group>. <article-title>Health of transgender adults in the US, 2014&#8211;2016</article-title>. <source>Am J Prev Med</source> (<year>2018</year>) <volume>55</volume>(<issue>3</issue>):<page-range>336&#8211;44</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.amepre.2018.04.045</pub-id><pub-id pub-id-type="pmid">30031640</pub-id></mixed-citation></ref><ref id="B19"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Prasad</surname><given-names>S</given-names></name><name name-style="western"><surname>Sung</surname><given-names>B</given-names></name><name name-style="western"><surname>Aggarwal</surname><given-names>BB</given-names></name></person-group>. <article-title>Age-associated chronic diseases require age-old medicine: Role of chronic inflammation</article-title>. <source>Prev Med</source> (<year>2012</year>) <volume>54</volume>:<page-range>S29&#8211;37</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.ypmed.2011.11.011</pub-id><pub-id pub-id-type="pmcid">PMC3340492</pub-id><pub-id pub-id-type="pmid">22178471</pub-id></mixed-citation></ref><ref id="B20"><label>20</label><mixed-citation publication-type="book"><person-group person-group-type="author"><collab>AAR</collab></person-group>. <source>Chronic conditions among older Americans</source>. <publisher-loc>Washington, DC</publisher-loc>: <publisher-name>AARP</publisher-name> (<year>2013</year>). Available at: <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://assets.aarp.org/rgcenter/health/beyond_50_hcr_conditions.pdf">http://assets.aarp.org/rgcenter/health/beyond_50_hcr_conditions.pdf</uri>.</mixed-citation></ref><ref id="B21"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fabbre</surname><given-names>V</given-names></name><name name-style="western"><surname>Gaveras</surname><given-names>E</given-names></name></person-group>. <article-title>The manifestation of multilevel stigma in the lived experiences of transgender and gender nonconforming older adults</article-title>. <source>Innovation Aging</source> (<year>2019</year>) <volume>3</volume>(<issue>Suppl 1</issue>):<page-range>S743&#8211;S</page-range>. doi: <pub-id pub-id-type="doi">10.1093/geroni/igz038.2722</pub-id><pub-id pub-id-type="pmcid">PMC7182477</pub-id><pub-id pub-id-type="pmid">31971406</pub-id></mixed-citation></ref><ref id="B22"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Witten</surname><given-names>TM</given-names></name></person-group>. <article-title>End of life, chronic illness, and trans-identities</article-title>. <source>J Soc Work End Life Palliat Care</source> (<year>2014</year>) <volume>10</volume>(<issue>1</issue>):<fpage>34</fpage>&#8211;<lpage>58</lpage>. doi: <pub-id pub-id-type="doi">10.1080/15524256.2013.877864</pub-id><pub-id pub-id-type="pmid">24628141</pub-id></mixed-citation></ref><ref id="B23"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Witten</surname><given-names>TM</given-names></name></person-group>. <article-title>The intersectional challenges of aging and of being a gender non-conforming adult</article-title>. <source>Generations</source> (<year>2016</year>) <volume>40</volume>(<issue>2</issue>):<fpage>63</fpage>&#8211;<lpage>70</lpage>. Available at: <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.jstor.org/stable/26556204">https://www.jstor.org/stable/26556204</uri>.</mixed-citation></ref><ref id="B24"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Addis</surname><given-names>S</given-names></name><name name-style="western"><surname>Davies</surname><given-names>M</given-names></name><name name-style="western"><surname>Greene</surname><given-names>G</given-names></name><name name-style="western"><surname>MacBride-Stewart</surname><given-names>S</given-names></name><name name-style="western"><surname>Shepherd</surname><given-names>M</given-names></name></person-group>. <article-title>The health, social care and housing needs of lesbian, gay, bisexual and transgender older people: A review of the literature</article-title>. <source>Health Soc Care Community</source> (<year>2009</year>) <volume>17</volume>(<issue>6</issue>):<page-range>647&#8211;58</page-range>. doi: <pub-id pub-id-type="doi">10.1111/j.1365-2524.2009.00866.x</pub-id><pub-id pub-id-type="pmid">19519872</pub-id></mixed-citation></ref><ref id="B25"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Finkenauer</surname><given-names>S</given-names></name><name name-style="western"><surname>Sherratt</surname><given-names>J</given-names></name><name name-style="western"><surname>Marlow</surname><given-names>J</given-names></name><name name-style="western"><surname>Brodey</surname><given-names>A</given-names></name></person-group>. <article-title>When injustice gets old: A systematic review of trans aging</article-title>. <source>J Gay Lesbian Soc Services</source> (<year>2012</year>) <volume>24</volume>(<issue>4</issue>):<page-range>311&#8211;30</page-range>. doi: <pub-id pub-id-type="doi">10.1080/10538720.2012.722497</pub-id></mixed-citation></ref><ref id="B26"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>White Hughto</surname><given-names>JM</given-names></name><name name-style="western"><surname>Reisner</surname><given-names>SL</given-names></name></person-group>. <article-title>Social context of depressive distress in aging transgender adults</article-title>. <source>J Appl Gerontol</source> (<year>2016</year>) <volume>37</volume>(<issue>12</issue>):<page-range>1517&#8211;39</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1177/0733464816675819</pub-id><pub-id pub-id-type="pmcid">PMC5411312</pub-id><pub-id pub-id-type="pmid">28380703</pub-id></mixed-citation></ref><ref id="B27"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cook-Daniels</surname><given-names>L</given-names></name><name name-style="western"><surname>Munson</surname><given-names>M</given-names></name></person-group>. <article-title>Sexual violence, elder abuse, and sexuality of transgender adults, age 50+: Results of three surveys</article-title>. <source>J GLBT Family Stud</source> (<year>2010</year>) <volume>6</volume>(<issue>2</issue>):<page-range>142&#8211;77</page-range>. doi: <pub-id pub-id-type="doi">10.1080/15504281003705238</pub-id></mixed-citation></ref><ref id="B28"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Porter</surname><given-names>KE</given-names></name><name name-style="western"><surname>Ronneberg</surname><given-names>CR</given-names></name><name name-style="western"><surname>Witten</surname><given-names>TM</given-names></name></person-group>. <article-title>Religious affiliation and successful aging among transgender older adults: Findings from the trans MetLife survey</article-title>. <source>J Religion Spirituality Aging</source> (<year>2013</year>) <volume>25</volume>(<issue>2</issue>):<page-range>112&#8211;38</page-range>. doi: <pub-id pub-id-type="doi">10.1080/15528030.2012.739988</pub-id></mixed-citation></ref><ref id="B29"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Progovac</surname><given-names>AM</given-names></name><name name-style="western"><surname>Mullin</surname><given-names>BO</given-names></name><name name-style="western"><surname>Dunham</surname><given-names>E</given-names></name><name name-style="western"><surname>Reisner</surname><given-names>SL</given-names></name><name name-style="western"><surname>McDowell</surname><given-names>A</given-names></name><name name-style="western"><surname>Roman</surname><given-names>MJS</given-names></name><etal/></person-group>. <article-title>Disparities in suicidality by gender identity among Medicare beneficiaries</article-title>. <source>Am J Prev Med</source> (<year>2020</year>) <volume>58</volume>(<issue>6</issue>):<page-range>789&#8211;98</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.amepre.2020.01.004</pub-id><pub-id pub-id-type="pmcid">PMC7246148</pub-id><pub-id pub-id-type="pmid">32156489</pub-id></mixed-citation></ref><ref id="B30"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dragon</surname><given-names>CN</given-names></name><name name-style="western"><surname>Guerino</surname><given-names>P</given-names></name><name name-style="western"><surname>Ewald</surname><given-names>E</given-names></name><name name-style="western"><surname>Laffan</surname><given-names>AM</given-names></name></person-group>. <article-title>Transgender Medicare beneficiaries and chronic conditions: Exploring fee-for-service claims data</article-title>. <source>LGBT Health</source> (<year>2017</year>) <volume>4</volume>(<issue>6</issue>):<page-range>404&#8211;11</page-range>. doi: <pub-id pub-id-type="doi">10.1089/lgbt.2016.0208</pub-id><pub-id pub-id-type="pmcid">PMC5731542</pub-id><pub-id pub-id-type="pmid">29125908</pub-id></mixed-citation></ref><ref id="B31"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Progovac</surname><given-names>AM</given-names></name><name name-style="western"><surname>Cook</surname><given-names>BL</given-names></name><name name-style="western"><surname>Mullin</surname><given-names>BO</given-names></name><name name-style="western"><surname>McDowell</surname><given-names>A</given-names></name><name name-style="western"><surname>Sanchez R</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>Identifying gender minority patients&#8217; health and health care needs in administrative claims data</article-title>. <source>Health Aff</source> (<year>2018</year>) <volume>37</volume>(<issue>3</issue>):<page-range>413&#8211;20</page-range>. doi: <pub-id pub-id-type="doi">10.1377/hlthaff.2017.1295</pub-id><pub-id pub-id-type="pmcid">PMC5942884</pub-id><pub-id pub-id-type="pmid">29505378</pub-id></mixed-citation></ref><ref id="B32"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pharr</surname><given-names>JR</given-names></name></person-group>. <article-title>Health disparities among lesbian, gay, bisexual, transgender, and nonbinary adults 50 years old and older in the United States</article-title>. <source>LGBT Health</source> (<year>2021</year>) <volume>8</volume>(<issue>7</issue>):<page-range>473&#8211;85</page-range>. doi: <pub-id pub-id-type="doi">10.1089/lgbt.2021.0009</pub-id><pub-id pub-id-type="pmid">34534016</pub-id></mixed-citation></ref><ref id="B33"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Proctor</surname><given-names>K</given-names></name><name name-style="western"><surname>Haffer</surname><given-names>SC</given-names></name><name name-style="western"><surname>Ewald</surname><given-names>E</given-names></name><name name-style="western"><surname>Hodge</surname><given-names>C</given-names></name><name name-style="western"><surname>James</surname><given-names>CV</given-names></name></person-group>. <article-title>Identifying the transgender population in the Medicare program</article-title>. <source>Trans Health</source> (<year>2016</year>) <volume>1</volume>(<issue>1</issue>):<page-range>250&#8211;65</page-range>. doi: <pub-id pub-id-type="doi">10.1089/trgh.2016.0031</pub-id><pub-id pub-id-type="pmcid">PMC5367475</pub-id><pub-id pub-id-type="pmid">28861539</pub-id></mixed-citation></ref><ref id="B34"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Reisner</surname><given-names>SL</given-names></name><name name-style="western"><surname>Greytak</surname><given-names>EA</given-names></name><name name-style="western"><surname>Parsons</surname><given-names>JT</given-names></name><name name-style="western"><surname>Ybarra</surname><given-names>ML</given-names></name></person-group>. <article-title>Gender minority social stress in adolescence: Disparities in adolescent bullying and substance use by gender identity</article-title>. <source>J Sex Res</source> (<year>2015</year>) <volume>52</volume>(<issue>3</issue>):<page-range>243&#8211;56</page-range>. doi: <pub-id pub-id-type="doi">10.1080/00224499.2014.886321</pub-id><pub-id pub-id-type="pmcid">PMC4201643</pub-id><pub-id pub-id-type="pmid">24742006</pub-id></mixed-citation></ref><ref id="B35"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Goldsen</surname><given-names>KIF</given-names></name><name name-style="western"><surname>Romanelli</surname><given-names>M</given-names></name><name name-style="western"><surname>Hoy-Ellis</surname><given-names>CP</given-names></name><name name-style="western"><surname>Jung</surname><given-names>H</given-names></name></person-group>. <article-title>Health, economic and social disparities among transgender women, transgender men and transgender nonbinary adults: Results from a population-based study</article-title>. <source>Prev Med</source> (<year>2022</year>) <volume>156</volume>:<fpage>106988</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ypmed.2022.106988</pub-id><pub-id pub-id-type="pmid">35150748</pub-id><pub-id pub-id-type="pmcid">PMC8954758</pub-id></mixed-citation></ref><ref id="B36"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yee</surname><given-names>K</given-names></name><name name-style="western"><surname>Lind</surname><given-names>BK</given-names></name><name name-style="western"><surname>Downing</surname><given-names>J</given-names></name></person-group>. <article-title>Change in gender on record and transgender adults&#8217; mental or behavioral health</article-title>. <source>Am J Prev Med</source> (<year>2021</year>) <volume>62</volume>(<issue>5</issue>):<page-range>696&#8211;704</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1016/j.amepre.2021.10.016</pub-id><pub-id pub-id-type="pmcid">PMC9035075</pub-id><pub-id pub-id-type="pmid">34920916</pub-id></mixed-citation></ref><ref id="B37"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moon</surname><given-names>M</given-names></name></person-group>. <article-title>What Medicare has meant to older Americans</article-title>. <source>Health Care Financ Rev</source> (<year>1996</year>) <volume>18</volume>(<issue>2</issue>):<page-range>49&#8211;59</page-range>.<pub-id pub-id-type="pmcid">PMC4193639</pub-id><pub-id pub-id-type="pmid">10167859</pub-id></mixed-citation></ref><ref id="B38"><label>38</label><mixed-citation publication-type="webpage"><person-group person-group-type="author"><collab>CMS</collab></person-group>. <source>Chronic conditions data warehouse: Centers for Medicare and Medicaid Services</source> (<year>2022</year>). Available at: <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www2.ccwdata.org/web/guest/condition-categories-chronic">https://www2.ccwdata.org/web/guest/condition-categories-chronic</uri>.</mixed-citation></ref><ref id="B39"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Restar</surname><given-names>A</given-names></name><name name-style="western"><surname>Jin</surname><given-names>H</given-names></name><name name-style="western"><surname>Operario</surname><given-names>D</given-names></name></person-group>. <article-title>Gender-inclusive and gender-specific approaches in trans health research</article-title>. <source>Transgend Health</source> (<year>2021</year>) <volume>6</volume>(<issue>5</issue>):<page-range>235&#8211;9</page-range>. doi: <pub-id pub-id-type="doi">10.1089/trgh.2020.0054</pub-id><pub-id pub-id-type="pmcid">PMC8664111</pub-id><pub-id pub-id-type="pmid">34993295</pub-id></mixed-citation></ref><ref id="B40"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McEwen</surname><given-names>BS</given-names></name><name name-style="western"><surname>Seeman</surname><given-names>T</given-names></name></person-group>. <article-title>Protective and damaging effects of mediators of stress: Elaborating and testing the concepts of allostasis and allostatic load</article-title>. <source>Ann N Y Acad Sci</source> (<year>1999</year>) <volume>896</volume>(<issue>1</issue>):<fpage>30</fpage>&#8211;<lpage>47</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1749-6632.1999.tb08103.x</pub-id><pub-id pub-id-type="pmid">10681886</pub-id></mixed-citation></ref><ref id="B41"><label>41</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McEwen</surname><given-names>BS</given-names></name></person-group>. <article-title>Stress, adaptation, and disease: Allostasis and allostatic load</article-title>. <source>Ann N Y Acad Sci</source> (<year>1998</year>) <volume>840</volume>(<issue>1</issue>):<fpage>33</fpage>&#8211;<lpage>44</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1749-6632.1998.tb09546.x</pub-id><pub-id pub-id-type="pmid">9629234</pub-id></mixed-citation></ref><ref id="B42"><label>42</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hughes</surname><given-names>LD</given-names></name><name name-style="western"><surname>King</surname><given-names>WM</given-names></name><name name-style="western"><surname>Gamarel</surname><given-names>KE</given-names></name><name name-style="western"><surname>Geronimus</surname><given-names>AT</given-names></name><name name-style="western"><surname>Panagiotou</surname><given-names>OA</given-names></name><name name-style="western"><surname>Hughto</surname><given-names>JMW</given-names></name></person-group>. <article-title>US Black&#8211;white differences in mortality risk among transgender and cisgender people in private insurance, 2011&#8211;2019</article-title>. <source>Am J Public Health</source> (<year>2022</year>) <volume>112</volume>(<issue>10</issue>):<page-range>1507&#8211;14</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.2105/AJPH.2022.306963</pub-id><pub-id pub-id-type="pmcid">PMC9480456</pub-id><pub-id pub-id-type="pmid">35981277</pub-id></mixed-citation></ref><ref id="B43"><label>43</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Juster</surname><given-names>R-P</given-names></name><name name-style="western"><surname>McEwen</surname><given-names>BS</given-names></name><name name-style="western"><surname>Lupien</surname><given-names>SJ</given-names></name></person-group>. <article-title>Allostatic load biomarkers of chronic stress and impact on health and cognition</article-title>. <source>Neurosci Biobehav Rev</source> (<year>2010</year>) <volume>35</volume>(<issue>1</issue>):<fpage>2</fpage>&#8211;<lpage>16</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.neubiorev.2009.10.002</pub-id><pub-id pub-id-type="pmid">19822172</pub-id></mixed-citation></ref><ref id="B44"><label>44</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Duru</surname><given-names>OK</given-names></name><name name-style="western"><surname>Harawa</surname><given-names>NT</given-names></name><name name-style="western"><surname>Kermah</surname><given-names>D</given-names></name><name name-style="western"><surname>Norris</surname><given-names>KC</given-names></name></person-group>. <article-title>Allostatic load burden and racial disparities in mortality</article-title>. <source>J Natl Med Assoc</source> (<year>2012</year>) <volume>104</volume>(<issue>1-2</issue>):<fpage>89</fpage>&#8211;<lpage>95</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0027-9684(15)30120-6</pub-id><pub-id pub-id-type="pmid">22708252</pub-id><pub-id pub-id-type="pmcid">PMC3417124</pub-id></mixed-citation></ref><ref id="B45"><label>45</label><mixed-citation publication-type="webpage"><person-group person-group-type="author"><collab>American Cancer Society</collab></person-group>. <article-title>Key statistics for breast cancer in men</article-title>. Available at: <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.cancer.org/cancer/breast-cancer-in-men/about/key-statistics.html">https://www.cancer.org/cancer/breast-cancer-in-men/about/key-statistics.html</uri>.</mixed-citation></ref><ref id="B46"><label>46</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>de Blok</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Wiepjes</surname><given-names>CM</given-names></name><name name-style="western"><surname>Nota</surname><given-names>NM</given-names></name><name name-style="western"><surname>van Engelen</surname><given-names>K</given-names></name><name name-style="western"><surname>Adank</surname><given-names>MA</given-names></name><name name-style="western"><surname>Dreijerink</surname><given-names>KM</given-names></name><etal/></person-group>. <article-title>Breast cancer risk in transgender people receiving hormone treatment: Nationwide cohort study in the Netherlands</article-title>. <source>BMJ</source> (<year>2019</year>) <volume>365</volume>:<fpage>l1652</fpage>. doi:&#160;<pub-id pub-id-type="doi">10.1136/bmj.l1652</pub-id><pub-id pub-id-type="pmid">31088823</pub-id><pub-id pub-id-type="pmcid">PMC6515308</pub-id></mixed-citation></ref><ref id="B47"><label>47</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Quinn</surname><given-names>VP</given-names></name><name name-style="western"><surname>Nash</surname><given-names>R</given-names></name><name name-style="western"><surname>Hunkeler</surname><given-names>E</given-names></name><name name-style="western"><surname>Contreras</surname><given-names>R</given-names></name><name name-style="western"><surname>Cromwell</surname><given-names>L</given-names></name><name name-style="western"><surname>Becerra-Culqui</surname><given-names>TA</given-names></name><etal/></person-group>. <article-title>Cohort profile: Study of transition, outcomes and gender (STRONG) to assess health status of transgender people</article-title>. <source>BMJ Open</source> (<year>2017</year>) <volume>7</volume>(<issue>12</issue>):<fpage>e018121</fpage>. doi: <pub-id pub-id-type="doi">10.1136/bmjopen-2017-018121</pub-id><pub-id pub-id-type="pmcid">PMC5770907</pub-id><pub-id pub-id-type="pmid">29284718</pub-id></mixed-citation></ref><ref id="B48"><label>48</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brown</surname><given-names>GR</given-names></name><name name-style="western"><surname>Jones</surname><given-names>KT</given-names></name></person-group>. <article-title>Incidence of breast cancer in a cohort of 5,135 transgender veterans</article-title>. <source>Breast Cancer Res Treat</source> (<year>2015</year>) <volume>149</volume>(<issue>1</issue>):<page-range>191&#8211;8</page-range>. doi: <pub-id pub-id-type="doi">10.1007/s10549-014-3213-2</pub-id><pub-id pub-id-type="pmid">25428790</pub-id></mixed-citation></ref><ref id="B49"><label>49</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brown</surname><given-names>GR</given-names></name></person-group>. <article-title>Breast cancer in transgender veterans: A ten-case series</article-title>. <source>LGBT Health</source> (<year>2015</year>) <volume>2</volume>(<issue>1</issue>):<fpage>77</fpage>&#8211;<lpage>80</lpage>. doi: <pub-id pub-id-type="doi">10.1089/lgbt.2014.0123</pub-id><pub-id pub-id-type="pmid">26790021</pub-id></mixed-citation></ref><ref id="B50"><label>50</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Braun</surname><given-names>H</given-names></name><name name-style="western"><surname>Nash</surname><given-names>R</given-names></name><name name-style="western"><surname>Tangpricha</surname><given-names>V</given-names></name><name name-style="western"><surname>Brockman</surname><given-names>J</given-names></name><name name-style="western"><surname>Ward</surname><given-names>K</given-names></name><name name-style="western"><surname>Goodman</surname><given-names>M</given-names></name></person-group>. <article-title>Cancer in transgender people: Evidence and methodological considerations</article-title>. <source>Epidemiol Rev</source> (<year>2017</year>) <volume>39</volume>(<issue>1</issue>):<fpage>93</fpage>&#8211;<lpage>107</lpage>. doi: <pub-id pub-id-type="doi">10.1093/epirev/mxw003</pub-id><pub-id pub-id-type="pmid">28486701</pub-id><pub-id pub-id-type="pmcid">PMC5868281</pub-id></mixed-citation></ref><ref id="B51"><label>51</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Reiche</surname><given-names>EMV</given-names></name><name name-style="western"><surname>Nunes</surname><given-names>SOV</given-names></name><name name-style="western"><surname>Morimoto</surname><given-names>HK</given-names></name></person-group>. <article-title>Stress, depression, the immune system, and cancer</article-title>. <source>Lancet Oncol</source> (<year>2004</year>) <volume>5</volume>(<issue>10</issue>):<page-range>617&#8211;25</page-range>. doi: <pub-id pub-id-type="doi">10.1016/S1470-2045(04)01597-9</pub-id><pub-id pub-id-type="pmid">15465465</pub-id></mixed-citation></ref><ref id="B52"><label>52</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moreno-Smith</surname><given-names>M</given-names></name><name name-style="western"><surname>Lutgendorf</surname><given-names>SK</given-names></name><name name-style="western"><surname>Sood</surname><given-names>AK</given-names></name></person-group>. <article-title>Impact of stress on cancer metastasis</article-title>. <source>Future Oncol</source> (<year>2010</year>) <volume>6</volume>(<issue>12</issue>):<page-range>1863&#8211;81</page-range>. doi: <pub-id pub-id-type="doi">10.2217/fon.10.142</pub-id><pub-id pub-id-type="pmcid">PMC3037818</pub-id><pub-id pub-id-type="pmid">21142861</pub-id></mixed-citation></ref><ref id="B53"><label>53</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weyers</surname><given-names>S</given-names></name><name name-style="western"><surname>Villeirs</surname><given-names>G</given-names></name><name name-style="western"><surname>Vanherreweghe</surname><given-names>E</given-names></name><name name-style="western"><surname>Verstraelen</surname><given-names>H</given-names></name><name name-style="western"><surname>Monstrey</surname><given-names>S</given-names></name><name name-style="western"><surname>Van den Broecke</surname><given-names>R</given-names></name><etal/></person-group>. <article-title>Mammography and breast sonography in transsexual women</article-title>. <source>Eur J Radiol</source> (<year>2010</year>) <volume>74</volume>(<issue>3</issue>):<page-range>508&#8211;13</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.ejrad.2009.03.018</pub-id><pub-id pub-id-type="pmid">19359116</pub-id></mixed-citation></ref><ref id="B54"><label>54</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brown</surname><given-names>SB</given-names></name><name name-style="western"><surname>Hankinson</surname><given-names>SE</given-names></name></person-group>. <article-title>Endogenous estrogens and the risk of breast, endometrial, and ovarian cancers</article-title>. <source>Steroids</source> (<year>2015</year>) <volume>99</volume>:<fpage>8</fpage>&#8211;<lpage>10</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.steroids.2014.12.013</pub-id><pub-id pub-id-type="pmid">25555473</pub-id></mixed-citation></ref><ref id="B55"><label>55</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chia</surname><given-names>K</given-names></name><name name-style="western"><surname>O&#8217;Brien</surname><given-names>M</given-names></name><name name-style="western"><surname>Brown</surname><given-names>M</given-names></name><name name-style="western"><surname>Lim</surname><given-names>E</given-names></name></person-group>. <article-title>Targeting the androgen receptor in breast cancer</article-title>. <source>Curr Oncol Rep</source> (<year>2015</year>) <volume>17</volume>(<issue>2</issue>):<fpage>1</fpage>&#8211;<lpage>6</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s11912-014-0427-8</pub-id><pub-id pub-id-type="pmid">25665553</pub-id></mixed-citation></ref><ref id="B56"><label>56</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McCormack</surname><given-names>VA</given-names></name><name name-style="western"><surname>dos Santos Silva</surname><given-names>I</given-names></name></person-group>. <article-title>Breast density and parenchymal patterns as markers of breast cancer risk: A meta-analysis</article-title>. <source>Cancer Epidemiol Biomark Prev</source> (<year>2006</year>) <volume>15</volume>(<issue>6</issue>):<page-range>1159&#8211;69</page-range>. doi: <pub-id pub-id-type="doi">10.1158/1055-9965.EPI-06-0034</pub-id><pub-id pub-id-type="pmid">16775176</pub-id></mixed-citation></ref><ref id="B57"><label>57</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>D&#8217;Alonzo</surname><given-names>M</given-names></name><name name-style="western"><surname>Bounous</surname><given-names>VE</given-names></name><name name-style="western"><surname>Villa</surname><given-names>M</given-names></name><name name-style="western"><surname>Biglia</surname><given-names>N</given-names></name></person-group>. <article-title>Current evidence of the oncological benefit-risk profile of hormone replacement therapy</article-title>. <source>Medicina (Mex)</source> (<year>2019</year>) <volume>55</volume>(<issue>9</issue>):<page-range>573&#8211;&#8211;80</page-range>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/medicina55090573</pub-id><pub-id pub-id-type="pmcid">PMC6780494</pub-id><pub-id pub-id-type="pmid">31500261</pub-id></mixed-citation></ref><ref id="B58"><label>58</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gambacciani</surname><given-names>M</given-names></name><name name-style="western"><surname>Cagnacci</surname><given-names>A</given-names></name><name name-style="western"><surname>Lello</surname><given-names>S</given-names></name></person-group>. <article-title>Hormone replacement therapy and prevention of chronic conditions</article-title>. <source>Climacteric</source> (<year>2019</year>) <volume>22</volume>(<issue>3</issue>):<page-range>303&#8211;6</page-range>. doi: <pub-id pub-id-type="doi">10.1080/13697137.2018.1551347</pub-id><pub-id pub-id-type="pmid">30626218</pub-id></mixed-citation></ref><ref id="B59"><label>59</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Coleman</surname><given-names>E</given-names></name><name name-style="western"><surname>Radix</surname><given-names>A</given-names></name><name name-style="western"><surname>Bouman</surname><given-names>W</given-names></name><name name-style="western"><surname>Brown</surname><given-names>G</given-names></name><name name-style="western"><surname>De Vries</surname><given-names>A</given-names></name><name name-style="western"><surname>Deutsch</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Standards of care for the health of transgender and gender diverse people, version 8</article-title>. <source>Int J Transgender Health</source> (<year>2022</year>) <volume>23</volume>(<issue>sup1</issue>):<page-range>S1&#8211;259</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1080/26895269.2022.2100644</pub-id><pub-id pub-id-type="pmcid">PMC9553112</pub-id><pub-id pub-id-type="pmid">36238954</pub-id></mixed-citation></ref><ref id="B60"><label>60</label><mixed-citation publication-type="book"><person-group person-group-type="author"><collab>CDC</collab></person-group>. <source>Rheumatoid arthritis (RA)</source>. <publisher-loc>Atlanta, GA</publisher-loc>: <publisher-name>Centers for Disease Control and Prevention</publisher-name> (<year>2022</year>). Available at: <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.cdc.gov/arthritis/basics/rheumatoid-arthritis.html#risk">https://www.cdc.gov/arthritis/basics/rheumatoid-arthritis.html#risk</uri>.</mixed-citation></ref><ref id="B61"><label>61</label><mixed-citation publication-type="book"><person-group person-group-type="author"><collab>CDC</collab></person-group>. <source>Arthritis risk factors</source>. <publisher-loc>Atlanta, GA</publisher-loc>: <publisher-name>Centers for Disease Control and Prevention</publisher-name> (<year>2022</year>). Available at: <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.cdc.gov/arthritis/basics/risk-factors.htm">https://www.cdc.gov/arthritis/basics/risk-factors.htm</uri>.</mixed-citation></ref><ref id="B62"><label>62</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pouresmaeili</surname><given-names>F</given-names></name><name name-style="western"><surname>Kamalidehghan</surname><given-names>B</given-names></name><name name-style="western"><surname>Kamarehei</surname><given-names>M</given-names></name><name name-style="western"><surname>Goh</surname><given-names>YM</given-names></name></person-group>. <article-title>A comprehensive overview on osteoporosis and its risk factors</article-title>. <source>Ther Clin Risk Manage</source> (<year>2018</year>) <volume>14</volume>:<fpage>2029</fpage>. doi: <pub-id pub-id-type="doi">10.2147/TCRM.S138000</pub-id><pub-id pub-id-type="pmcid">PMC6225907</pub-id><pub-id pub-id-type="pmid">30464484</pub-id></mixed-citation></ref><ref id="B63"><label>63</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jiang</surname><given-names>P</given-names></name><name name-style="western"><surname>Li</surname><given-names>H</given-names></name><name name-style="western"><surname>Li</surname><given-names>X</given-names></name></person-group>. <article-title>Diabetes mellitus risk factors in rheumatoid arthritis: A systematic review and meta-analysis</article-title>. <source>Clin Exp Rheumatol</source> (<year>2015</year>) <volume>33</volume>(<issue>1</issue>):<page-range>115&#8211;21</page-range>.<pub-id pub-id-type="pmid">25535750</pub-id></mixed-citation></ref><ref id="B64"><label>64</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Caceres</surname><given-names>BA</given-names></name><name name-style="western"><surname>Jackman</surname><given-names>KB</given-names></name><name name-style="western"><surname>Edmondson</surname><given-names>D</given-names></name><name name-style="western"><surname>Bockting</surname><given-names>WO</given-names></name></person-group>. <article-title>Assessing gender identity differences in cardiovascular disease in US adults: An analysis of data from the 2014&#8211;2017 BRFSS</article-title>. <source>J Behav Med</source> (<year>2020</year>) <volume>43</volume>(<issue>2</issue>):<page-range>329&#8211;38</page-range>. doi: <pub-id pub-id-type="doi">10.1007/s10865-019-00102-8</pub-id><pub-id pub-id-type="pmcid">PMC7899707</pub-id><pub-id pub-id-type="pmid">31559524</pub-id></mixed-citation></ref><ref id="B65"><label>65</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alzahrani</surname><given-names>T</given-names></name><name name-style="western"><surname>Nguyen</surname><given-names>T</given-names></name><name name-style="western"><surname>Ryan</surname><given-names>A</given-names></name><name name-style="western"><surname>Dwairy</surname><given-names>A</given-names></name><name name-style="western"><surname>McCaffrey</surname><given-names>J</given-names></name><name name-style="western"><surname>Yunus</surname><given-names>R</given-names></name><etal/></person-group>. <article-title>Cardiovascular disease risk factors and myocardial infarction in the transgender population</article-title>. <source>Circ Cardiovasc Qual Outcomes</source> (<year>2019</year>) <volume>12</volume>(<issue>4</issue>):<fpage>e005597</fpage>. doi: <pub-id pub-id-type="doi">10.1161/CIRCOUTCOMES.119.005597</pub-id><pub-id pub-id-type="pmid">30950651</pub-id></mixed-citation></ref><ref id="B66"><label>66</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kyinn</surname><given-names>M</given-names></name><name name-style="western"><surname>Banks</surname><given-names>K</given-names></name><name name-style="western"><surname>Leemaqz</surname><given-names>S</given-names></name><name name-style="western"><surname>Sarkodie</surname><given-names>E</given-names></name><name name-style="western"><surname>Goldstein</surname><given-names>D</given-names></name><name name-style="western"><surname>Irwig</surname><given-names>M</given-names></name></person-group>. <article-title>Weight gain and obesity rates in transgender and gender-diverse adults before and during hormone therapy</article-title>. <source>Int J Obes</source> (<year>2021</year>) <volume>45</volume>(<issue>12</issue>):<page-range>2562&#8211;9</page-range>. doi: <pub-id pub-id-type="doi">10.1038/s41366-021-00935-x</pub-id><pub-id pub-id-type="pmid">34400797</pub-id></mixed-citation></ref><ref id="B67"><label>67</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Deutsch</surname><given-names>MB</given-names></name></person-group>. <source>Guidelines for the primary and gender-affirming care of transgender and gender nonbinary people</source>. <publisher-loc>San Francisco, CA</publisher-loc>: <publisher-name>University of California-San Francisco</publisher-name> (<year>2016</year>).</mixed-citation></ref><ref id="B68"><label>68</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cosman</surname><given-names>F</given-names></name><name name-style="western"><surname>de Beur</surname><given-names>SJ</given-names></name><name name-style="western"><surname>LeBoff</surname><given-names>M</given-names></name><name name-style="western"><surname>Lewiecki</surname><given-names>E</given-names></name><name name-style="western"><surname>Tanner</surname><given-names>B</given-names></name><name name-style="western"><surname>Randall</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Clinician&#8217;s guide to prevention and treatment of osteoporosis</article-title>. <source>Osteoporosis Int</source> (<year>2014</year>) <volume>25</volume>(<issue>10</issue>):<page-range>2359&#8211;81</page-range>. doi: <pub-id pub-id-type="doi">10.1007/s00198-014-2794-2</pub-id><pub-id pub-id-type="pmcid">PMC4176573</pub-id><pub-id pub-id-type="pmid">25182228</pub-id></mixed-citation></ref><ref id="B69"><label>69</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mehler</surname><given-names>PS</given-names></name><name name-style="western"><surname>Cleary</surname><given-names>BS</given-names></name><name name-style="western"><surname>Gaudiani</surname><given-names>JL</given-names></name></person-group>. <article-title>Osteoporosis in anorexia nervosa</article-title>. <source>Eating Disord</source> (<year>2011</year>) <volume>19</volume>(<issue>2</issue>):<fpage>194</fpage>&#8211;<lpage>202</lpage>. doi: <pub-id pub-id-type="doi">10.1080/10640266.2011.551636</pub-id><pub-id pub-id-type="pmid">21360368</pub-id></mixed-citation></ref><ref id="B70"><label>70</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jones</surname><given-names>BA</given-names></name><name name-style="western"><surname>Arcelus</surname><given-names>J</given-names></name><name name-style="western"><surname>Bouman</surname><given-names>WP</given-names></name><name name-style="western"><surname>Haycraft</surname><given-names>E</given-names></name></person-group>. <article-title>Barriers and facilitators of physical activity and sport participation among young transgender adults who are medically transitioning</article-title>. <source>Int J Transgend</source> (<year>2017</year>) <volume>18</volume>(<issue>2</issue>):<page-range>227&#8211;38</page-range>. doi: <pub-id pub-id-type="doi">10.1080/15532739.2017.1293581</pub-id></mixed-citation></ref><ref id="B71"><label>71</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jones</surname><given-names>BA</given-names></name><name name-style="western"><surname>Haycraft</surname><given-names>E</given-names></name><name name-style="western"><surname>Bouman</surname><given-names>WP</given-names></name><name name-style="western"><surname>Arcelus</surname><given-names>J</given-names></name></person-group>. <article-title>The levels and predictors of physical activity engagement within the treatment-seeking transgender population: A matched control study</article-title>. <source>J Phys Act Health</source> (<year>2018</year>) <volume>15</volume>(<issue>2</issue>):<fpage>99</fpage>&#8211;<lpage>107</lpage>. doi: <pub-id pub-id-type="doi">10.1123/jpah.2017-0298</pub-id><pub-id pub-id-type="pmid">28872406</pub-id></mixed-citation></ref><ref id="B72"><label>72</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oliveira</surname><given-names>J</given-names></name><name name-style="western"><surname>Frontini</surname><given-names>R</given-names></name><name name-style="western"><surname>Jacinto</surname><given-names>M</given-names></name><name name-style="western"><surname>Antunes</surname><given-names>R</given-names></name></person-group>. <article-title>Barriers and motives for physical activity and sports practice among trans people: A systematic review</article-title>. <source>Sustainability</source> (<year>2022</year>) <volume>14</volume>(<issue>9</issue>):<page-range>5295&#8211;5306</page-range>. doi: <pub-id pub-id-type="doi">10.3390/su14095295</pub-id></mixed-citation></ref><ref id="B73"><label>73</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lawless</surname><given-names>MH</given-names></name><name name-style="western"><surname>Harrison</surname><given-names>KA</given-names></name><name name-style="western"><surname>Grandits</surname><given-names>GA</given-names></name><name name-style="western"><surname>Eberly</surname><given-names>LE</given-names></name><name name-style="western"><surname>Allen</surname><given-names>SS</given-names></name></person-group>. <article-title>Perceived stress and smoking-related behaviors and symptomatology in male and female smokers</article-title>. <source>Addict Behav</source> (<year>2015</year>) <volume>51</volume>:<page-range>80&#8211;3</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.addbeh.2015.07.011</pub-id><pub-id pub-id-type="pmcid">PMC4558262</pub-id><pub-id pub-id-type="pmid">26240941</pub-id></mixed-citation></ref><ref id="B74"><label>74</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Almeida</surname><given-names>M</given-names></name><name name-style="western"><surname>Laurent</surname><given-names>MR</given-names></name><name name-style="western"><surname>Dubois</surname><given-names>V</given-names></name><name name-style="western"><surname>Claessens</surname><given-names>F</given-names></name><name name-style="western"><surname>O'Brien</surname><given-names>CA</given-names></name><name name-style="western"><surname>Bouillon</surname><given-names>R</given-names></name><etal/></person-group>. <article-title>Estrogens and androgens in skeletal physiology and pathophysiology</article-title>. <source>Physiol Rev</source> (<year>2017</year>) <volume>97</volume>(<issue>1</issue>):<page-range>135&#8211;87</page-range>. doi: <pub-id pub-id-type="doi">10.1152/physrev.00033.2015</pub-id><pub-id pub-id-type="pmcid">PMC5539371</pub-id><pub-id pub-id-type="pmid">27807202</pub-id></mixed-citation></ref><ref id="B75"><label>75</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Manolagas</surname><given-names>SC</given-names></name></person-group>. <article-title>Birth and death of bone cells: Basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis</article-title>. <source>Endocr Rev</source> (<year>2000</year>) <volume>21</volume>(<issue>2</issue>):<page-range>115&#8211;37</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1210/edrv.21.2.0395</pub-id><pub-id pub-id-type="pmid">10782361</pub-id></mixed-citation></ref><ref id="B76"><label>76</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Irwig</surname><given-names>MS</given-names></name></person-group>. <article-title>Testosterone therapy for transgender men</article-title>. <source>Lancet Diabetes Endocrinol</source> (<year>2017</year>) <volume>5</volume>(<issue>4</issue>):<page-range>301&#8211;11</page-range>. doi: <pub-id pub-id-type="doi">10.1016/S2213-8587(16)00036-X</pub-id><pub-id pub-id-type="pmid">27084565</pub-id></mixed-citation></ref><ref id="B77"><label>77</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Singh-Ospina</surname><given-names>N</given-names></name><name name-style="western"><surname>Maraka</surname><given-names>S</given-names></name><name name-style="western"><surname>Rodriguez-Gutierrez</surname><given-names>R</given-names></name><name name-style="western"><surname>Davidge-Pitts</surname><given-names>C</given-names></name><name name-style="western"><surname>Nippoldt</surname><given-names>TB</given-names></name><name name-style="western"><surname>Prokop</surname><given-names>LJ</given-names></name><etal/></person-group>. <article-title>Effect of sex steroids on the bone health of transgender individuals: A systematic review and meta-analysis</article-title>. <source>J Clin Endocrinol Metab</source> (<year>2017</year>) <volume>102</volume>(<issue>11</issue>):<page-range>3904&#8211;13</page-range>. doi: <pub-id pub-id-type="doi">10.1210/jc.2017-01642</pub-id><pub-id pub-id-type="pmid">28945851</pub-id></mixed-citation></ref><ref id="B78"><label>78</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wiepjes</surname><given-names>CM</given-names></name><name name-style="western"><surname>Vlot</surname><given-names>MC</given-names></name><name name-style="western"><surname>Klaver</surname><given-names>M</given-names></name><name name-style="western"><surname>Nota</surname><given-names>NM</given-names></name><name name-style="western"><surname>de Blok</surname><given-names>CJ</given-names></name><name name-style="western"><surname>de Jongh</surname><given-names>RT</given-names></name><etal/></person-group>. <article-title>Bone mineral density increases in trans persons after 1 year of hormonal treatment: A multicenter prospective observational study</article-title>. <source>J Bone Mineral Res</source> (<year>2017</year>) <volume>32</volume>(<issue>6</issue>):<page-range>1252&#8211;60</page-range>. doi: <pub-id pub-id-type="doi">10.1002/jbmr.3102</pub-id><pub-id pub-id-type="pmid">28370342</pub-id></mixed-citation></ref><ref id="B79"><label>79</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Motta</surname><given-names>G</given-names></name><name name-style="western"><surname>Marinelli</surname><given-names>L</given-names></name><name name-style="western"><surname>Barale</surname><given-names>M</given-names></name><name name-style="western"><surname>Brustio</surname><given-names>PR</given-names></name><name name-style="western"><surname>Manieri</surname><given-names>C</given-names></name><name name-style="western"><surname>Ghigo</surname><given-names>E</given-names></name><etal/></person-group>. <article-title>Fracture risk assessment in an Italian group of transgender women after gender-confirming surgery</article-title>. <source>J Bone Mineral Metab</source> (<year>2020</year>) <volume>38</volume>(<issue>6</issue>):<page-range>885&#8211;93</page-range>. doi: <pub-id pub-id-type="doi">10.1007/s00774-020-01127-9</pub-id><pub-id pub-id-type="pmid">32691168</pub-id></mixed-citation></ref><ref id="B80"><label>80</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Klink</surname><given-names>D</given-names></name><name name-style="western"><surname>Caris</surname><given-names>M</given-names></name><name name-style="western"><surname>Heijboer</surname><given-names>A</given-names></name><name name-style="western"><surname>van Trotsenburg</surname><given-names>M</given-names></name><name name-style="western"><surname>Rotteveel</surname><given-names>J</given-names></name></person-group>. <article-title>Bone mass in young adulthood following gonadotropin-releasing hormone analog treatment and cross-sex hormone treatment in adolescents with gender dysphoria</article-title>. <source>J Clin Endocrinol Metab</source> (<year>2015</year>) <volume>100</volume>(<issue>2</issue>):<page-range>E270&#8211;E5</page-range>. doi: <pub-id pub-id-type="doi">10.1210/jc.2014-2439</pub-id><pub-id pub-id-type="pmid">25427144</pub-id></mixed-citation></ref><ref id="B81"><label>81</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rich</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Scheim</surname><given-names>AI</given-names></name><name name-style="western"><surname>Koehoorn</surname><given-names>M</given-names></name><name name-style="western"><surname>Poteat</surname><given-names>T</given-names></name></person-group>. <article-title>Non-HIV chronic disease burden among transgender populations globally: A systematic review and narrative synthesis</article-title>. <source>Prev Med Rep</source> (<year>2020</year>) <volume>20</volume>:<fpage>101259</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.pmedr.2020.101259</pub-id><pub-id pub-id-type="pmid">33335828</pub-id><pub-id pub-id-type="pmcid">PMC7732872</pub-id></mixed-citation></ref><ref id="B82"><label>82</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Salk</surname><given-names>RH</given-names></name><name name-style="western"><surname>Hyde</surname><given-names>JS</given-names></name><name name-style="western"><surname>Abramson</surname><given-names>LY</given-names></name></person-group>. <article-title>Gender differences in depression in representative national samples: Meta-analyses of diagnoses and symptoms</article-title>. <source>Psychol Bull</source> (<year>2017</year>) <volume>143</volume>(<issue>8</issue>):<fpage>783</fpage>&#8211;<lpage>822</lpage>. doi: <pub-id pub-id-type="doi">10.1037/bul0000102</pub-id><pub-id pub-id-type="pmid">28447828</pub-id><pub-id pub-id-type="pmcid">PMC5532074</pub-id></mixed-citation></ref><ref id="B83"><label>83</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Eid</surname><given-names>RS</given-names></name><name name-style="western"><surname>Gobinath</surname><given-names>AR</given-names></name><name name-style="western"><surname>Galea</surname><given-names>LA</given-names></name></person-group>. <article-title>Sex differences in depression: Insights from clinical and preclinical studies</article-title>. <source>Prog Neurobiol</source> (<year>2019</year>) <volume>176</volume>:<fpage>86</fpage>&#8211;<lpage>102</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.pneurobio.2019.01.006</pub-id><pub-id pub-id-type="pmid">30721749</pub-id></mixed-citation></ref><ref id="B84"><label>84</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guo</surname><given-names>Y</given-names></name><name name-style="western"><surname>Li</surname><given-names>Q</given-names></name><name name-style="western"><surname>Yang</surname><given-names>X</given-names></name><name name-style="western"><surname>Jaffee</surname><given-names>MS</given-names></name><name name-style="western"><surname>Wu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wang</surname><given-names>F</given-names></name><etal/></person-group>. <article-title>Prevalence of Alzheimer&#8217;s and related dementia diseases and risk factors among transgender adults, Florida, 2012&#8722;2020</article-title>. <source>Am J Public Health</source> (<year>2022</year>) <volume>112</volume>(<issue>5</issue>):<page-range>754&#8211;7</page-range>. doi: <pub-id pub-id-type="doi">10.2105/AJPH.2022.306720</pub-id><pub-id pub-id-type="pmcid">PMC9010917</pub-id><pub-id pub-id-type="pmid">35324265</pub-id></mixed-citation></ref><ref id="B85"><label>85</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barr</surname><given-names>SM</given-names></name><name name-style="western"><surname>Roberts</surname><given-names>D</given-names></name><name name-style="western"><surname>Thakkar</surname><given-names>KN</given-names></name></person-group>. <article-title>Psychosis in transgender and gender non-conforming individuals: A review of the literature and a call for more research</article-title>. <source>Psychiatry Res</source> (<year>2021</year>) <volume>306</volume>:<fpage>114272</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.psychres.2021.114272</pub-id><pub-id pub-id-type="pmid">34808496</pub-id></mixed-citation></ref><ref id="B86"><label>86</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Coleman</surname><given-names>E</given-names></name><name name-style="western"><surname>Bockting</surname><given-names>W</given-names></name><name name-style="western"><surname>Botzer</surname><given-names>M</given-names></name><name name-style="western"><surname>Cohen-Kettenis</surname><given-names>P</given-names></name><name name-style="western"><surname>DeCuypere</surname><given-names>G</given-names></name><name name-style="western"><surname>Feldman</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Standards of care for the health of transsexual, transgender, and gender-nonconforming people, version 7</article-title>. <source>Int J Transgend</source> (<year>2012</year>) <volume>13</volume>(<issue>4</issue>):<fpage>165</fpage>&#8211;<lpage>232</lpage>. doi: <pub-id pub-id-type="doi">10.1080/15532739.2011.700873</pub-id></mixed-citation></ref><ref id="B87"><label>87</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ashley</surname><given-names>F</given-names></name></person-group>. <article-title>Gatekeeping hormone replacement therapy for transgender patients is dehumanising</article-title>. <source>J Med Ethics</source> (<year>2019</year>) <volume>45</volume>(<issue>7</issue>):<page-range>480&#8211;2</page-range>. doi: <pub-id pub-id-type="doi">10.1136/medethics-2018-105293</pub-id><pub-id pub-id-type="pmid">30988174</pub-id></mixed-citation></ref><ref id="B88"><label>88</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schulz</surname><given-names>SL</given-names></name></person-group>. <article-title>The informed consent model of transgender care: An alternative to the diagnosis of gender dysphoria</article-title>. <source>J Humanistic Psychol</source> (<year>2018</year>) <volume>58</volume>(<issue>1</issue>):<fpage>72</fpage>&#8211;<lpage>92</lpage>. doi: <pub-id pub-id-type="doi">10.1177/0022167817745217</pub-id></mixed-citation></ref><ref id="B89"><label>89</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Br&#228;nstr&#246;m</surname><given-names>R</given-names></name><name name-style="western"><surname>Stormbom</surname><given-names>I</given-names></name><name name-style="western"><surname>Bergendal</surname><given-names>M</given-names></name><name name-style="western"><surname>Pachankis</surname><given-names>JE</given-names></name></person-group>. <article-title>Transgender-based disparities in suicidality: A population-based study of key predictions from four theoretical models</article-title>. <source>Suicide Life Threat Behav</source> (<year>2022</year>) <volume>52</volume>(<issue>3</issue>):<page-range>401&#8211;12</page-range>. doi: <pub-id pub-id-type="doi">10.1111/sltb.12830</pub-id><pub-id pub-id-type="pmcid">PMC10138751</pub-id><pub-id pub-id-type="pmid">35067978</pub-id></mixed-citation></ref><ref id="B90"><label>90</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Brennan</surname><given-names>G</given-names></name></person-group>. <article-title>Stress vulnerability model and serious mental illness</article-title>. <source>Working with serious mental illness: A manual for clinical practice</source>. <publisher-loc>Edinburgh, UK</publisher-loc>: <publisher-name>Bailliere Tindall</publisher-name>. (<year>2000</year>). pp. <fpage>29</fpage>&#8211;<lpage>39</lpage>.</mixed-citation></ref><ref id="B91"><label>91</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Fleming</surname><given-names>MP</given-names></name><name name-style="western"><surname>Martin</surname><given-names>CR</given-names></name></person-group>. <article-title>Trauma exposure, schizophrenia symptoms, and the stress vulnerability model</article-title>. In: <person-group person-group-type="editor"><name name-style="western"><surname>Martin</surname><given-names>C</given-names></name><name name-style="western"><surname>Preedy</surname><given-names>V</given-names></name><name name-style="western"><surname>Patel</surname><given-names>V</given-names></name></person-group>, editors. <source>Comprehensive guide to post-traumatic stress disorders</source>. <publisher-loc>Switzerland</publisher-loc>: <publisher-name>Springer International Publishing</publisher-name> (<year>2015</year>). p. <page-range>1&#8211;20</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1007/978-3-319-08613-2_40-1</pub-id></mixed-citation></ref><ref id="B92"><label>92</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Greenberg</surname><given-names>MS</given-names></name><name name-style="western"><surname>Tanev</surname><given-names>K</given-names></name><name name-style="western"><surname>Marin</surname><given-names>MF</given-names></name><name name-style="western"><surname>Pitman</surname><given-names>RK</given-names></name></person-group>. <article-title>Stress, PTSD, and dementia</article-title>. <source>Alzheimers Dement</source> (<year>2014</year>) <volume>10</volume>:<page-range>S155&#8211;S65</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.jalz.2014.04.008</pub-id><pub-id pub-id-type="pmid">24924667</pub-id></mixed-citation></ref><ref id="B93"><label>93</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hammen</surname><given-names>C</given-names></name></person-group>. <article-title>Stress and depression</article-title>. <source>Annu Rev Clin Psychology</source> (<year>2005</year>) <volume>1</volume>:<page-range>293&#8211;319</page-range>. doi: <pub-id pub-id-type="doi">10.1146/annurev.clinpsy.1.102803.143938</pub-id><pub-id pub-id-type="pmid">17716090</pub-id></mixed-citation></ref><ref id="B94"><label>94</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McEwen</surname><given-names>BS</given-names></name></person-group>. <article-title>Allostasis and allostatic load: Implications for neuropsychopharmacology</article-title>. <source>Neuropsychopharmacology</source> (<year>2000</year>) <volume>22</volume>(<issue>2</issue>):<page-range>108&#8211;24</page-range>. doi: <pub-id pub-id-type="doi">10.1016/S0893-133X(99)00129-3</pub-id><pub-id pub-id-type="pmid">10649824</pub-id></mixed-citation></ref><ref id="B95"><label>95</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>DuBois</surname><given-names>LZ</given-names></name><name name-style="western"><surname>Juster</surname><given-names>R-P</given-names></name></person-group>. <article-title>Lived experience and allostatic load among transmasculine people living in the United States</article-title>. <source>Psychoneuroendocrinology</source> (<year>2022</year>) <volume>143</volume>:<fpage>105849</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.psyneuen.2022.105849</pub-id><pub-id pub-id-type="pmid">35797839</pub-id></mixed-citation></ref><ref id="B96"><label>96</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lambrou</surname><given-names>NH</given-names></name><name name-style="western"><surname>Gleason</surname><given-names>CE</given-names></name><name name-style="western"><surname>Obedin-Maliver</surname><given-names>J</given-names></name><name name-style="western"><surname>Lunn</surname><given-names>MR</given-names></name><name name-style="western"><surname>Flentje</surname><given-names>A</given-names></name><name name-style="western"><surname>Lubensky</surname><given-names>ME</given-names></name><etal/></person-group>. <article-title>Subjective cognitive decline associated with discrimination in medical settings among transgender and nonbinary older adults</article-title>. <source>Int J Environ Res Public Health</source> (<year>2022</year>) <volume>19</volume>(<issue>15</issue>):<fpage>9168</fpage>. doi: <pub-id pub-id-type="doi">10.3390/ijerph19159168</pub-id><pub-id pub-id-type="pmid">35954522</pub-id><pub-id pub-id-type="pmcid">PMC9368374</pub-id></mixed-citation></ref><ref id="B97"><label>97</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Valente</surname><given-names>PK</given-names></name><name name-style="western"><surname>Dworkin</surname><given-names>JD</given-names></name><name name-style="western"><surname>Dolezal</surname><given-names>C</given-names></name><name name-style="western"><surname>Singh</surname><given-names>AA</given-names></name><name name-style="western"><surname>LeBlanc</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Bockting</surname><given-names>WO</given-names></name></person-group>. <article-title>Prospective relationships between stigma, mental health, and resilience in a multi-city cohort of transgender and nonbinary individuals in the United States, 2016&#8211;2019</article-title>. <source>Soc Psychiatry Psychiatr Epidemiol</source> (<year>2022</year>) <volume>57</volume>(<issue>7</issue>):<page-range>1445&#8211;56</page-range>. doi: <pub-id pub-id-type="doi">10.1007/s00127-022-02270-6</pub-id><pub-id pub-id-type="pmid">35312828</pub-id></mixed-citation></ref><ref id="B98"><label>98</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stutterheim</surname><given-names>SE</given-names></name><name name-style="western"><surname>van Dijk</surname><given-names>M</given-names></name><name name-style="western"><surname>Wang</surname><given-names>H</given-names></name><name name-style="western"><surname>Jonas</surname><given-names>KJ</given-names></name></person-group>. <article-title>The worldwide burden of HIV in transgender individuals: An updated systematic review and meta-analysis</article-title>. <source>PLoS One</source> (<year>2021</year>) <volume>16</volume>(<issue>12</issue>):<elocation-id>e0260063</elocation-id>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0260063</pub-id><pub-id pub-id-type="pmid">34851961</pub-id><pub-id pub-id-type="pmcid">PMC8635361</pub-id></mixed-citation></ref><ref id="B99"><label>99</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Becasen</surname><given-names>JS</given-names></name><name name-style="western"><surname>Denard</surname><given-names>CL</given-names></name><name name-style="western"><surname>Mullins</surname><given-names>MM</given-names></name><name name-style="western"><surname>Higa</surname><given-names>DH</given-names></name><name name-style="western"><surname>Sipe</surname><given-names>TA</given-names></name></person-group>. <article-title>Estimating the prevalence of HIV and sexual behaviors among the US transgender population: A systematic review and meta-analysis, 2006&#8211;2017</article-title>. <source>Am J Public Health</source> (<year>2019</year>) <volume>109</volume>(<issue>1</issue>):<page-range>e1&#8211;8</page-range>. doi: <pub-id pub-id-type="doi">10.2105/AJPH.2018.304727</pub-id><pub-id pub-id-type="pmcid">PMC6301428</pub-id><pub-id pub-id-type="pmid">30496000</pub-id></mixed-citation></ref><ref id="B100"><label>100</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Poteat</surname><given-names>T</given-names></name><name name-style="western"><surname>Scheim</surname><given-names>A</given-names></name><name name-style="western"><surname>Xavier</surname><given-names>J</given-names></name><name name-style="western"><surname>Reisner</surname><given-names>S</given-names></name><name name-style="western"><surname>Baral</surname><given-names>S</given-names></name></person-group>. <article-title>Global epidemiology of HIV infection and related syndemics affecting transgender people</article-title>. <source>J Acquir Immune Defic Syndr</source> (<year>2016</year>) <volume>72</volume>(<issue>Suppl 3</issue>):<page-range>S210&#8211;S9</page-range>. doi: <pub-id pub-id-type="doi">10.1097/QAI.0000000000001087</pub-id><pub-id pub-id-type="pmcid">PMC4969059</pub-id><pub-id pub-id-type="pmid">27429185</pub-id></mixed-citation></ref><ref id="B101"><label>101</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sevelius</surname><given-names>JM</given-names></name></person-group>. <article-title>Gender affirmation: A framework for conceptualizing risk behavior among transgender women of color</article-title>. <source>Sex Roles</source> (<year>2013</year>) <volume>68</volume>(<issue>11-12</issue>):<page-range>675&#8211;89</page-range>. doi: <pub-id pub-id-type="doi">10.1007/s11199-012-0216-5</pub-id><pub-id pub-id-type="pmcid">PMC3667985</pub-id><pub-id pub-id-type="pmid">23729971</pub-id></mixed-citation></ref><ref id="B102"><label>102</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Melendez</surname><given-names>RM</given-names></name><name name-style="western"><surname>Pinto</surname><given-names>R</given-names></name></person-group>. <article-title>&#8216;It's really a hard life&#8217;: Love, gender and HIV risk among male-to-female transgender persons</article-title>. <source>Cult Health Sex</source> (<year>2007</year>) <volume>9</volume>(<issue>3</issue>):<page-range>233&#8211;45</page-range>. doi: <pub-id pub-id-type="doi">10.1080/13691050601065909</pub-id><pub-id pub-id-type="pmcid">PMC3539165</pub-id><pub-id pub-id-type="pmid">17457728</pub-id></mixed-citation></ref><ref id="B103"><label>103</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Blair</surname><given-names>KL</given-names></name><name name-style="western"><surname>Hoskin</surname><given-names>RA</given-names></name></person-group>. <article-title>Transgender exclusion from the world of dating: Patterns of acceptance and rejection of hypothetical trans dating partners as a function of sexual and gender identity</article-title>. <source>J Soc Pers Relationships</source> (<year>2019</year>) <volume>36</volume>(<issue>7</issue>):<page-range>2074&#8211;95</page-range>. doi: <pub-id pub-id-type="doi">10.1177/0265407518779139</pub-id></mixed-citation></ref><ref id="B104"><label>104</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gamarel</surname><given-names>KE</given-names></name><name name-style="western"><surname>Reisner</surname><given-names>SL</given-names></name><name name-style="western"><surname>Laurenceau</surname><given-names>J-P</given-names></name><name name-style="western"><surname>Nemoto</surname><given-names>T</given-names></name><name name-style="western"><surname>Operario</surname><given-names>D</given-names></name></person-group>. <article-title>Gender minority stress, mental health, and relationship quality: A dyadic investigation of transgender women and their cisgender male partners</article-title>. <source>J Fam Psychol</source> (<year>2014</year>) <volume>28</volume>(<issue>4</issue>):<page-range>437&#8211;47</page-range>. doi: <pub-id pub-id-type="doi">10.1037/a0037171</pub-id><pub-id pub-id-type="pmcid">PMC4122619</pub-id><pub-id pub-id-type="pmid">24932942</pub-id></mixed-citation></ref><ref id="B105"><label>105</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chandler</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Creasy</surname><given-names>SL</given-names></name><name name-style="western"><surname>Adams</surname><given-names>BJ</given-names></name><name name-style="western"><surname>Eaton</surname><given-names>LA</given-names></name><name name-style="western"><surname>Bukowski</surname><given-names>LA</given-names></name><name name-style="western"><surname>Egan</surname><given-names>JE</given-names></name><etal/></person-group>. <article-title>Characterizing biomedical HIV prevention awareness and use among black transgender women in the United States</article-title>. <source>AIDS Behavior</source> (<year>2021</year>) <volume>25</volume>(<issue>9</issue>):<page-range>2929&#8211;40</page-range>. doi: <pub-id pub-id-type="doi">10.1007/s10461-021-03189-w</pub-id><pub-id pub-id-type="pmcid">PMC8374008</pub-id><pub-id pub-id-type="pmid">33606134</pub-id></mixed-citation></ref><ref id="B106"><label>106</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wilson</surname><given-names>E</given-names></name><name name-style="western"><surname>Rapues</surname><given-names>J</given-names></name><name name-style="western"><surname>Jin</surname><given-names>H</given-names></name><name name-style="western"><surname>Raymond</surname><given-names>HF</given-names></name></person-group>. <article-title>The use and correlates of illicit silicone or &#8220;fillers&#8221; in a population-based sample of transwomen, San Francisco, 2013</article-title>. <source>J Sexual Med</source> (<year>2014</year>) <volume>11</volume>(<issue>7</issue>):<page-range>1717&#8211;24</page-range>. doi: <pub-id pub-id-type="doi">10.1111/jsm.12558</pub-id><pub-id pub-id-type="pmcid">PMC4304636</pub-id><pub-id pub-id-type="pmid">24810672</pub-id></mixed-citation></ref><ref id="B107"><label>107</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Benotsch</surname><given-names>EG</given-names></name><name name-style="western"><surname>Zimmerman</surname><given-names>RS</given-names></name><name name-style="western"><surname>Cathers</surname><given-names>L</given-names></name><name name-style="western"><surname>Pierce</surname><given-names>J</given-names></name><name name-style="western"><surname>McNulty</surname><given-names>S</given-names></name><name name-style="western"><surname>Heck</surname><given-names>T</given-names></name><etal/></person-group>. <article-title>Non-medical use of prescription drugs and HIV risk behaviour in transgender women in the mid-Atlantic region of the United States</article-title>. <source>Int J STD AIDS</source> (<year>2016</year>) <volume>27</volume>(<issue>9</issue>):<page-range>776&#8211;82</page-range>. doi: <pub-id pub-id-type="doi">10.1177/0956462415595319</pub-id><pub-id pub-id-type="pmid">26185044</pub-id></mixed-citation></ref><ref id="B108"><label>108</label><mixed-citation publication-type="book"><person-group person-group-type="author"><collab>SAMHSA</collab></person-group>. <source>Key substance use and mental health indicators in the United States: Results from the 2017 National Survey on Drug Use and Health</source>. <publisher-loc>Rockville, MD</publisher-loc>: <publisher-name>Center for Behavioral Health Statistics and Quality</publisher-name> (<year>2018</year>). Available at: <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.samhsa.gov/data/">https://www.samhsa.gov/data/</uri>.</mixed-citation></ref><ref id="B109"><label>109</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wolfe</surname><given-names>HL</given-names></name><name name-style="western"><surname>Biello</surname><given-names>KB</given-names></name><name name-style="western"><surname>Reisner</surname><given-names>SL</given-names></name><name name-style="western"><surname>Mimiaga</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Cahill</surname><given-names>SR</given-names></name><name name-style="western"><surname>Hughto</surname><given-names>JMW</given-names></name></person-group>. <article-title>Transgender-related discrimination and substance use, substance use disorder diagnosis and treatment history among transgender adults</article-title>. <source>Drug Alcohol Depend</source> (<year>2021</year>) <volume>223</volume>:<fpage>108711</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.drugalcdep.2021.108711</pub-id><pub-id pub-id-type="pmid">33866073</pub-id><pub-id pub-id-type="pmcid">PMC8114322</pub-id></mixed-citation></ref><ref id="B110"><label>110</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McHugh</surname><given-names>RK</given-names></name><name name-style="western"><surname>Votaw</surname><given-names>VR</given-names></name><name name-style="western"><surname>Sugarman</surname><given-names>DE</given-names></name><name name-style="western"><surname>Greenfield</surname><given-names>SF</given-names></name></person-group>. <article-title>Sex and gender differences in substance use disorders</article-title>. <source>Clin Psychol Rev</source> (<year>2018</year>) <volume>66</volume>:<fpage>12</fpage>&#8211;<lpage>23</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cpr.2017.10.012</pub-id><pub-id pub-id-type="pmid">29174306</pub-id><pub-id pub-id-type="pmcid">PMC5945349</pub-id></mixed-citation></ref><ref id="B111"><label>111</label><mixed-citation publication-type="webpage"><person-group person-group-type="author"><collab>NIDA</collab></person-group>. <source>Sex and gender differences in substance use</source> (<year>2022</year>). Available at: <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://nida.nih.gov/publications/research-reports/substance-use-in-women/sex-gender-differences-in-substance-use">https://nida.nih.gov/publications/research-reports/substance-use-in-women/sex-gender-differences-in-substance-use</uri>.</mixed-citation></ref><ref id="B112"><label>112</label><mixed-citation publication-type="confproc"><person-group person-group-type="author"><name name-style="western"><surname>Adrian</surname><given-names>H</given-names></name><name name-style="western"><surname>Collins</surname><given-names>A</given-names></name><name name-style="western"><surname>Operario</surname><given-names>D</given-names></name><name name-style="western"><surname>Wolfe</surname><given-names>H</given-names></name><name name-style="western"><surname>Fern&#225;ndez</surname><given-names>Y</given-names></name><name name-style="western"><surname>Briody</surname><given-names>V</given-names></name><etal/></person-group>. <article-title>Providing gender-affirmative substance use disorder services for transgender and gender diverse people who use drugs in Rhode Island: A qualitative study</article-title>. <conf-name>Paper presented at: The American Public Health Association Annual Meeting</conf-name>, <conf-loc>Boston, MA</conf-loc>. (<year>2022</year>).</mixed-citation></ref><ref id="B113"><label>113</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lombardi</surname><given-names>E</given-names></name></person-group>. <article-title>Substance use treatment experiences of transgender/transsexual men and women</article-title>. <source>J LGBT Health Res</source> (<year>2007</year>) <volume>3</volume>(<issue>2</issue>):<fpage>37</fpage>&#8211;<lpage>47</lpage>. doi: <pub-id pub-id-type="doi">10.1300/J463v03n02_05</pub-id><pub-id pub-id-type="pmid">19835040</pub-id></mixed-citation></ref><ref id="B114"><label>114</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lyons</surname><given-names>T</given-names></name><name name-style="western"><surname>Shannon</surname><given-names>K</given-names></name><name name-style="western"><surname>Pierre</surname><given-names>L</given-names></name><name name-style="western"><surname>Small</surname><given-names>W</given-names></name><name name-style="western"><surname>Kr&#252;si</surname><given-names>A</given-names></name><name name-style="western"><surname>Kerr</surname><given-names>T</given-names></name></person-group>. <article-title>A qualitative study of transgender individuals&#8217; experiences in residential addiction treatment settings: Stigma and inclusivity</article-title>. <source>Subst Abuse Treat Prev Policy</source> (<year>2015</year>) <volume>10</volume>(<issue>1</issue>):<page-range>17&#8211;23</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1186/s13011-015-0015-4</pub-id><pub-id pub-id-type="pmcid">PMC4432520</pub-id><pub-id pub-id-type="pmid">25948286</pub-id></mixed-citation></ref><ref id="B115"><label>115</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Budge</surname><given-names>SL</given-names></name><name name-style="western"><surname>Katz-Wise</surname><given-names>SL</given-names></name><name name-style="western"><surname>Tebbe</surname><given-names>EN</given-names></name><name name-style="western"><surname>Howard</surname><given-names>KA</given-names></name><name name-style="western"><surname>Schneider</surname><given-names>CL</given-names></name><name name-style="western"><surname>Rodriguez</surname><given-names>A</given-names></name></person-group>. <article-title>Transgender emotional and coping processes: Facilitative and avoidant coping throughout gender transitioning</article-title>. <source>Couns Psychol</source> (<year>2013</year>) <volume>41</volume>(<issue>4</issue>):<page-range>601&#8211;47</page-range>. doi: <pub-id pub-id-type="doi">10.1177/0011000011432753</pub-id></mixed-citation></ref><ref id="B116"><label>116</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>White Hughto</surname><given-names>J</given-names></name><name name-style="western"><surname>Pachankis</surname><given-names>J</given-names></name><name name-style="western"><surname>Willie</surname><given-names>T</given-names></name><name name-style="western"><surname>Reisner</surname><given-names>S</given-names></name></person-group>. <article-title>Victimization and depressive symptomology in transgender adults: The mediating role of avoidant coping</article-title>. <source>J Couns Psychol</source> (<year>2017</year>) <volume>64</volume>(<issue>1</issue>):<fpage>41</fpage>&#8211;<lpage>51</lpage>. doi: <pub-id pub-id-type="doi">10.1037/cou0000184</pub-id><pub-id pub-id-type="pmid">28068130</pub-id><pub-id pub-id-type="pmcid">PMC5226079</pub-id></mixed-citation></ref><ref id="B117"><label>117</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Glynn</surname><given-names>TR</given-names></name><name name-style="western"><surname>van den Berg</surname><given-names>JJ</given-names></name></person-group>. <article-title>A systematic review of interventions to reduce problematic substance use among transgender individuals: A call to action</article-title>. <source>Transgend Health</source> (<year>2017</year>) <volume>2</volume>(<issue>1</issue>):<fpage>45</fpage>&#8211;<lpage>59</lpage>. doi: <pub-id pub-id-type="doi">10.1089/trgh.2016.0037</pub-id><pub-id pub-id-type="pmid">28861547</pub-id><pub-id pub-id-type="pmcid">PMC5549596</pub-id></mixed-citation></ref><ref id="B118"><label>118</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>White Hughto</surname><given-names>J</given-names></name><name name-style="western"><surname>Reisner</surname><given-names>S</given-names></name></person-group>. <article-title>A systematic review of the effects of hormone therapy on psychological functioning and quality of life in transgender individuals</article-title>. <source>Transgend Health</source> (<year>2016</year>) <volume>1</volume>(<issue>1</issue>):<fpage>21</fpage>&#8211;<lpage>31</lpage>. doi: <pub-id pub-id-type="doi">10.1089/trgh.2015.0008</pub-id><pub-id pub-id-type="pmid">27595141</pub-id><pub-id pub-id-type="pmcid">PMC5010234</pub-id></mixed-citation></ref><ref id="B119"><label>119</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Murad</surname><given-names>MH</given-names></name><name name-style="western"><surname>Elamin</surname><given-names>MB</given-names></name><name name-style="western"><surname>Garcia</surname><given-names>MZ</given-names></name><name name-style="western"><surname>Mullan</surname><given-names>RJ</given-names></name><name name-style="western"><surname>Murad</surname><given-names>A</given-names></name><name name-style="western"><surname>Erwin</surname><given-names>PJ</given-names></name><etal/></person-group>. <article-title>Hormonal therapy and sex reassignment: A systematic review and meta-analysis of quality of life and psychosocial outcomes</article-title>. <source>Clin Endocrinol (Oxf)</source> (<year>2010</year>) <volume>72</volume>(<issue>2</issue>):<page-range>214&#8211;31</page-range>. doi: <pub-id pub-id-type="doi">10.1111/j.1365-2265.2009.03625.x</pub-id><pub-id pub-id-type="pmid">19473181</pub-id></mixed-citation></ref><ref id="B120"><label>120</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Reisner</surname><given-names>SL</given-names></name><name name-style="western"><surname>Hughto</surname><given-names>JM</given-names></name></person-group>. <article-title>Comparing the health of non-binary and binary transgender adults in a statewide non-probability sample</article-title>. <source>PLoS One</source> (<year>2019</year>) <volume>14</volume>(<issue>8</issue>):<fpage>e0221583</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0221583</pub-id><pub-id pub-id-type="pmid">31454395</pub-id><pub-id pub-id-type="pmcid">PMC6711503</pub-id></mixed-citation></ref><ref id="B121"><label>121</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Boyer</surname><given-names>TL</given-names></name><name name-style="western"><surname>Youk</surname><given-names>AO</given-names></name><name name-style="western"><surname>Haas</surname><given-names>AP</given-names></name><name name-style="western"><surname>Brown</surname><given-names>GR</given-names></name><name name-style="western"><surname>Shipherd</surname><given-names>JC</given-names></name><name name-style="western"><surname>Kauth</surname><given-names>MR</given-names></name><etal/></person-group>. <article-title>Suicide, homicide, and all-cause mortality among transgender and cisgender patients in the Veterans Health Administration</article-title>. <source>LGBT Health</source> (<year>2021</year>) <volume>8</volume>(<issue>3</issue>):<page-range>173&#8211;80</page-range>. doi: <pub-id pub-id-type="doi">10.1089/lgbt.2020.0235</pub-id><pub-id pub-id-type="pmid">33544021</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>